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1 Summary 
Summary  
 
Cystic fibrosis (CF), the most common autosomal recessive disease among Caucasians, is caused by 
mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR).  
Among the wide spectrum of clinical and phenotypic manifestations occurring in CF, lung pathology 
is the main cause of morbidity and mortality. Progressive airway disease, chronic non-resolving 
inflammation, persistent bacterial infection are already observed in the majority of young children 
with CF. The prolonged airway inflammatory response induces permanent damage of CF airways 
leading to the loss of lung function in the majority of CF patients.  
In this respect, treatments with corticosteroids and ibuprofen have demonstrated potential benefits in 
CF patients, even though limited efficacy or the occurrence of side effects. For these reasons, the 
identification and the development of novel and more powerful anti-inflammatory drugs for CF 
airway disease remains a priority.  
Despite intensive research of the past few decades, the mechanisms involved in the onset of CF lung 
disease are not fully understood. Increasing lines of evidence highlighted the involvement of 
sphingolipids (SLs) in the development of CF lung pathology. SLs are cell membrane amphiphilic 
components that are located mainly in the external layer of the plasma membrane (PM) where they 
play important roles in the modulation of fundamental cell functions. Previous studies have 
demonstrated an abnormal SL metabolism in CF lung disease. In particular, increased levels of 
ceramide derived from sphingomyelin hydrolysis are related to the pro-inflammatory state as well as 
the inflammation response to bacterial infection occurring in CF lung disease. In addition, a recent 
study provides the evidence that ceramide derived from glycosphingolipid degradation (GSL) is 
involved in the inflammation response to bacterial infection of CF human epithelial bronchial cells; 
these data demonstrated that the pharmacological inhibition of GBA2, whose enzymatic activity 
produces ceramide at the cell surface, is associated with a significant reduction of the inflammatory 
response to P. aeruginosa infection. Moreover, GBA2 down-regulation reduces the intrinsic pro-
inflammatory state typical of CF bronchial cells. 
On the bases of these findings, the first aim of my PhD project was to study the possible correlation 
between ceramide formed at the PM through the action of the PM glycohydrolases and IL-8 release 
and expression. 
The obtained results suggest that in CF bronchial epithelial cells, P. aeruginosa infection promotes 
the recruitment in restricted area of PM of the all glycohydrolases necessary for the complete GSL 
catabolism. At this site, the presence of both enzymes and their substrates allows a rapid and local 
change of PM architecture; this event, together with the formation of ceramide-enriched platforms 
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might form a macromolecular complex involved in the activation of the inflammatory response. In 
this context, I found that GBA2 could play an important role in the development of the pro-
inflammatory state typical of CF lung disease.  
In particular, GBA2 silencing could represent a new promising therapeutic strategy to reduce both 
the pro-inflammatory state and the inflammatory response to bacterial infection in CF bronchial 
epithelial cells.  On these bases, the second objective of my PhD project was to set up a new strategy 
for GBA2-targeted siRNA delivery in CF epithelial bronchial cells. To this purpose, in collaboration 
with a group of biophysicists, I developed a lipid-based carrier to promote the transfection of genetic 
material. We developed two kinds of vehicles; DC-Chol/DOPE mixture assembled with siRNA 
(Lipoplex) and a DC-Chol/DOPE mixture with a siRNA pre-condensed with protamine 
(Nanoparticles). Our results showed that the Nanoparticles represented the most promising system to 
down-regulate GBA2 activity. 
Collectively, the results obtained in this study strongly support a role for GBA2 in the establishment 
of the pro-inflammatory state of CF. This finding provides promising bases for the use of modulators 
of SL metabolism as possible therapeutic strategies for CF lung inflammation.
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Introduction 
Cystic Fibrosis 
 
Cystic fibrosis is the most common autosomal genetic recessive disease among Caucasians, affecting 
approximately 1 in 2500-4000 newborns. The main cause of CF is the mutation of gene that encodes 
for the cystic fibrosis transmembrane conductance regulator (CFTR). 
The principal phenotype of CF is represented by the accumulation of viscous mucus at the epithelial 
surface of different organs as lungs, pancreas, gut and testes, which often results in inflammation and 
organ failure. CF patients usually die at an early age, mostly due to chronic lung infection and 
inflammation [O'Sullivan and Freedman, et al. 2009]. 
Thanks to the currently available CF therapies, the mean life of patients is increased from 5 year in 
the 1970s to around 35-40 years of age today [Borthwick, Botha, et al. 2011]. 
 
 CFTR gene and tissue expression 
 
The gene responsible for the cystic fibrosis disorder was identified in 1989 and is located to the long 
arm of chromosome 7 (7q31). The gene spans 190 Kb of genomic DNA and is composed by 27 exons 
[Kerem, Rommens, et al. 1989];[Riordan, Rommens, et al. 1989];[Rommens, Iannuzzi, et al. 1989]. 
The full-length CFTR mRNA contains 6128 nucleotides. All the CFTR transcription mechanisms 
start from around the same site but are also present some mechanisms of alternative splicing. The 
promoter region is characterized by consensus binding sites for different transcriptions factors as AP-
1, SP1, GRE, CRE, C/EBP. In addition, CFTR expression is regulated by hormone in both males and 
females [Tsui and Dorfman, et al. 2013].  
The expression of CFTR was deeply analyzed in both rodents and humans [Ellsworth, Jamison, et al. 
2000]. CFTR mRNA is constitutively expressed in sweat gland and in gastrointestinal tract in early 
development, [Trezise, Chambers, et al. 1993] and is maintained for the all-adult life.  
In particular, its expression is present in intestinal crypt cells, pancreatic duct, and acinar cells. CFTR 
is also expressed in mucin secretory cells, in gallbladder epithelia and in the Brunner glands. 
Measurable levels of CFTR were also detected in female and male reproductive tissue and organs, 
such as cervix, endometrium, fallopian tubes, and ovary as well as in epididymis head. Low and 
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intermediate levels of CFTR transcripts can also be found in kidney, thyroid and salivary gland 
[Stoltz, Meyerholz, et al. 2015]. 
The lung is a special case [Engelhardt, Zepeda, et al. 1994]. The expression patterns of CFTR in the 
fetus are maintained postnatally, except in the respiratory system. In fact, high levels of CFTR 
expression are found in the epithelium of the conducting airways in the fetal lung and this finding is 
in markedly contrast to the relative lack of expression detected in the adult lung. On the other hand, 
expression in submucosal gland is present only after birth, and not measurable in fetus, in fact in adult 
respiratory tissue the main site of expression of CFTR is the serous submucosal gland [McCarthy and 
Harris, et al. 2005, Tizzano and Buchwald, et al. 1995, Tsui and Dorfman, et al. 2013].  
 
CFTR protein: function and structure 
 
CFTR functions as ions channel, with specificity for chloride and bicarbonate, regulates Cl-/HCO3
- 
exchanges at the level of the apical membranes of epithelial cells in multiple organs [Anderson, 
Gregory, et al. 1991].  
Through its role of chloride-bicarbonate exchanger, CFTR appears to influence local pH and thus 
ionic content and fluid on epithelial surface, events crucial for the formation of functional airway 
surface liquid in bronchial epithelia [Poulsen, Fischer, et al. 1994];[Weiser, Molenda, et al. 2011]. In 
addition, the local pH generated by CFTR activity, influences other ion channels including the 
epithelial sodium channel ENaC in the airways [Borowitz, et al. 2015]. 
Concerning the structure, CFTR is a protein composed by 1480 amino-acid residue and is a member 
of the ATP-binding cassette (ABC) transporter family. It has a typical ABC transporter architecture: 
two trans-membrane domains (TMDs) connected by four intracellular linkers, ICL1-ICL4, two 
nucleotide-binding domains (NBDs), a regulatory region (R), and N-/C- terminal extension (figure 
1).  The two trans-membrane domains are composed of six membrane-spanning α-helices and are 
predicted to form a pore for ions passage. NBD1 has an additional 35 residues insertion and NBD2 
has 80 residues extension at its end, if compared with other ABC proteins. These additional peptides 
may be regulate CFTR channel interaction with other cellular molecules.  
The regulatory region R is a random coil highly charged, is about 200 residues in length and is 
characterized by several consensus sequences (12 serines and 8 threonines) for protein kinase A 
(PKA) phosphorylation. The four intra-cellular loops are predicted to interact and transduce 
information between TMDs and NBDs [Moran, et al. 2014]. 
Channel activity has been described by three state for CFTR: open, closed and open-ready, the open 
ready conformation is poised to rapidly transitions into open state. CFTR activity is also dependent   
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on the presence of ATP and PKA phosphorylation of its R region, indeed phosphorylation of the R 
region is important for opening CFTR channel. 
 
 
CFTR biogenesis 
  
CFTR folding is a crucial point during the protein synthesis and only 30% of all immature CFTR 
polypeptide chains reaches the plasma membrane in mature state. In comparison, other ABC proteins 
are processed in a more efficient way [Cant, Pollock, et al. 2014] 
The synthesis of CFTR and the first step of folding control occur in the endoplasmic reticulum (ER), 
by chaperons protein like Calnexin, Aha and HSP40/70/90. Both inter and intra-domain folding is 
required for ER exit.  
The plasma membrane (PM) provides the final stages of CFTR maturation, indeed CFTR at the PM 
level takes part in an interactome, which probably includes members of Rab and Rho families of 
GTPase and cytoskeleton proteins, such as the PDZ-interacting NHERF protein [Cant, Pollock, et al. 
2014].  
A complete glycosylation at 4th extracellular loop (residue 894 and 900), characterizes the correct and 
mature folded state of CFTR, even if this modification is not essential for the correct channel activity 
and PM localization of the protein. Some other different post-translational modifications like 
methylation, palmitoylation, and phosphorylation are important for correct folding, biological activity 
and protein stability [Cant, Pollock, et al. 2014]. 
  
Figure 1 Theoretical domain organization of CFTR at the apical membrane [Milla and Moss, et al. 2015] 
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Classification of CFTR mutations 
 
Over 1000 mutations have been identified in the CFTR gene [McCharty et al 2005 Pulmonology]. 
Five major classes of CFTR mutations were described, according to: i) consequences on CFTR 
function, ii) impaired protein synthesis, iii) effects on maturation, iv) aberrant channel regulation, and 
v) defective channel conductance (figure 2). Classes I-III cause severe disease phenotypes whereas 
class IV and V/VI are generally mild-disease causing mutations [Farinha and Matos, et al. 2016]; 
[Cant, Pollock, et al. 2014, Fanen, Wohlhuter-Haddad, et al. 2014].  
Class I mutations affect CFTR protein synthesis, resulting in the total or partial lack of protein 
production. Common mutations in this class are nucleotide substitutions introducing a premature stop 
codon (W1282X, G542X and R1162X), frame-shifting insertions or deletions, mutations in splice-
junctions, a complete or partial deletion of CFTR gene or alteration that leads to changes in the exon 
sequence. G542X is the most frequent mutation of this class and leads to a reduced steady state level 
of mRNA, caused by the presence of a premature stop codon in its sequences.  
Class II mutations affect the protein folding process and can be find within any CFTR domain. Even 
if it is translated into full-length nascent polypeptide, the misfolded protein is retained in the 
endoplasmic reticulum, targeted for degradation by the ubiquitin/proteasome pathway, rather than 
trafficked to the PM. 
The most frequent CF mutation belonged to this class is the p.Phe508del. This kind of mutation causes 
an energetic instability of NBD1 because of the uncorrected local folding.  
Class III is composed by missense mutations, which affect frequently the ATP binding domains 
(NBD1 and NBD2), leading to gating defects. The produced CFTR is able to reach the plasma 
membrane but has decreased channel opening time and decreased chloride flux, caused by resistance 
to activation by protein Kinase A. The most described mutation of class III is p.Gly551Asp. 
Class IV mutations alter the CFTR membrane spanning domains involved in the structure of the 
channel. Consequently, these mutations afflict the correct channel conductance, even when the gate 
is open. Recently, the subclass IVb has been identified, in relation to mutations involving defects in 
CFTR bicarbonate conductance only.  
Class V mutations are localized in the splicing-sites, leading to alteration in the proper exon 
recognition. As results, CFTR is fully functional at the plasma membrane but in low content, because 
of defective in mRNA splicing. The most frequent and well-studied is the skipping of exon 10 [Fanen, 
Wohlhuter-Haddad, et al. 2014].  
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Class VI include mutations that decrease the retention and stability of CFTR at the cell surface. 
Recently, class VI mutations were combined with class V, as mutations leading to a reduced amount 
of functional CFTR protein [Cant, Pollock, et al. 2014, Fanen,Wohlhuter-Haddad, et al. 2014, Farinha 
and Matos, et al. 2016].  
 
 
Figure 2 Classes of CFTR mutations [Elborn, et al. 2016] 
 
 Clinical manifestations of Cystic Fibrosis 
 
The clinical manifestations of CF comprise a very wide spectrum of symptoms; this great variability 
is due, not only to the type of CFTR mutations, but also to other genetic and environmental factors, 
like lifestyle and therapeutic treatment. 
The general clinical spectrum of CF include pancreatic, hepatic and pulmonary manifestation like 
pancreatic insufficiency, chronic or recurrent acute pancreatitis, biliary obstruction, sino-pulmonary 
manifestations as sinusitis, sputum production, airway obstruction, opportunistic pathogens in airway 
secretions, recurrent infections. Symptoms include also reproductive abnormalities as obstructive 
azoospermia, infertility and gastro-intestinal abnormalities like meconium ileus, distal intestinal 
obstruction syndrome and rectal prolapse [Fanen, Wohlhuter-Haddad, et al. 2014]. 
  
 
8 Introduction 
Since, as described above, the clinical spectrum of CF has greatly expanded, the current diagnostic 
practice classifies patients with classic and non-classic CF. To date, the more reliable test for CF 
clinical diagnose and classification is the sweat test.  
The majority of patients has classic CF, this kind of patients has a sweat chloride concentration of    
(> 60 mmol/L) and severe multi-organ phenotype, and their organs are affected to varying degrees. 
Their mortality is principally due to progressive respiratory disease. From a genetic point of view, 
patients with classic CF have one established CF-causing mutation on each CFTR allele.   
Non-classic CF individuals have a normal (<30 mmol/L) or borderline (30-60 mmol/L) sweat 
chloride level and generally at least milder single organ phenotype [Tizzano and Buchwald, et al. 
1995]. 
The partition of classic and non-classic CF allows the establishment of classification of CFTR 
mutations into four groups, according to their clinical consequences [Castellani, Cuppens, et al. 
2008]. 
Group A comprises mutations that cause classic CF (CF-causing), group B includes mutations that 
cause non-classic CF (associated with CFTR-related disorders), group C comprises mutations with 
not known clinical consequences and group D consists of mutations with unknown or uncertain 
clinical relevance. It is important to note that CFTR genotype is not a useful predictor of the severity 
of lung disease in the individual patient, and should not be used as an indicator of prognosis.   
 
Cystic fibrosis lung disease and inflammation 
 
Among all these clinical and phenotypic manifestation of CF, the main cause of morbidity and 
mortality in patients is progressive lung disease. CF airways are characterized by permanent structural 
damage and impaired lung function caused by high-intensity inflammation and inefficiency of 
clearing pathogens [Chmiel, Berger, et al. 2002]. The most common pathologic findings are 
bronchiectasis, airways obstruction and chronic infection driven by different bacteria, in particular by 
Pseudomonas aeruginosa [Chmiel and Davis, et al. 2003]. 
Scientist studied a large number of defects of the CF lung disease and inflammation, directly or 
indirectly correlated to CFTR like airway surface liquid and mucociliary clearance, the low pH of 
airway surface liquid and some sphingolipids abnormalities [Becker, Riethmuller, et al. 2010]; 
[Boucher, et al. 2007].  
The airway mucus is a complex and dynamic viscous colloid that can continuously modify in response 
to different signals from the environment. The mucus contains different molecules as antibacterial 
defensins, immunoglobulin, inorganic salts, mucins and other proteins. Thanks to these components, 
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the airway mucus is able to explicate different functions, as to create a protective barrier against toxic 
products and to clear pathogens. The mucus must be sufficiently fluid to allow the elimination of 
particles and pathogens. The presence of CFTR influences the characteristics of the airway surface 
liquid and mucus layer [Perez-Vilar and Boucher, et al. 2004]. 
First of all the water content of airway surface liquid is regulated by CFTR, thanks to its capacity to 
secrete chloride ions and control sodium adsorption. The impaired regulation of sodium and chloride 
content in CF, caused by the absence of CFTR, leads to a defective osmotic pressure, an increased 
absorption of water and consequently to a dehydration of the airway surface liquid [Boucher, et al. 
2007]; [Nichols and Chmiel, et al. 2015]. The most important consequence of an increase water 
absorption is the formation of a very viscous mucus unable to eliminate bacteria, leading to a chronic 
retention of pathogens and a strong inflammatory response [Cantin, Hartl, et al. 2015, Hoegger, 
Fischer, et al. 2014].  
Some evidence suggest that CFTR is also important for the regulation of bicarbonate secretion and 
influences the local pH in the airway epithelium. Normal airway surface liquid has a pH of 7.0. In 
individual with CF, pH is lower; in particular, eight fold more acidic supporting the idea that CFTR 
is fundamental for the airway acid-base balance [Coakley, Grubb, et al. 2003].  
Local pH is essential for the correct functionality of different proteins. In particular, characteristic 
proteins called mucins, principally MUC5A, MUC5B, and MUC2, which are able to attract water in 
the mucus [De Lisle, et al. 2009].  
Mucins can be transmembrane, present on the apical part of epithelial cells, or can float as a gel. Both 
these kinds of mucins are localized in the periciliary space and form a protective barrier.  
Some findings suggest that the correct solubilization and distribution of mucins in the surface 
epithelium is a pH dependent phenomenon, regulated by the action of CFTR. 
In particular, mucins before secretions are highly packaged in a small granules, sequestered by 
electrical charge given by cations as, Calcium. Bicarbonate secreted by CFTR is able to displace 
cations, leading to the solubilization of mucins granules. The absence of bicarbonate causes the 
formation of dense layer of mucins, tightly adherent to the epithelium surface. [Cantin, Hartl, et al. 
2015] [Boucher, et al. 2002, Nichols and Chmiel, et al. 2015] 
In addition the low pH at the airway surface, results in the inactivation of proteins with antimicrobial 
properties [Pezzulo, Tang, et al. 2012]. 
For example, the function of pH-sensitive SPLUNC-1, that is normally able to create a strong host 
defense, is compromised.   
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Sphingolipids  
 
Plasma membrane is composed by and extremely complex lipid composition including 
glycerophospholipids, cholesterol and sphingolipids [van Meer and Vaz, et al. 2005]. 
Glycerophospholipids are the main lipids of eukaryotic cell membranes. Sphingolipids (SLs) are 
minor component of the cell [Degroote, Wolthoorn, et al. 2004], and their name derives from the 
Greek word Sphinx, with the meaning of enigmatic. In the past, many of their functions remained 
unknown for a long time, but today the functions of sphingolipids have become very wide and various 
[Futerman and Hannun, et al. 2004]. 
SLs are amphipathic molecules, associated mainly with the external leaflet of the plasma membrane, 
characterized by a hydrophobic group inserted into the cellular lipid bilayer and a hydrophilic group 
protruding toward the extracellular environment [Merrill, et al. 2011]. 
They have a common structure which comprises a backbone called “long-chain” or “sphingoid” 
bases, which is represented by a 2-amino-1,3-dihydroxy-octadec-4-ene, an amino alcohol called 
sphingosine. Sphingosine has potentially four different chemical configuration, but only the 2S, 3R 
is found in nature. It is the most abundant “sphingoid” base found in mammals and is typically present 
linked with a long or very long- chain fatty acid, through an amide-bound. The fatty acid chain are 
predominantly 14 to 36 carbon atoms in length and usually saturated [Carter, Glick, et al. 1947].  
The N-acylated form of sphingosine is called Ceramide (Cer), and is the hydrophobic lipid moiety of 
sphingolipids. Cer is the starting point for the biosynthesis of the more complex sphingolipids and 
glycosphingolipids (GSLs) [Merrill, et al. 2011]. 
The hydrophilic head group R of sphingolipids is represented by phosphocoline in the case of 
sphingomyelin or by an oligosaccharide chain in the case of glycosphingolipids. A particular class of 
glycosphingolipids has the oligosaccharide that contains a sialic acid residue, and is called 
Gangliosides [Merrill, et al. 2011]. 
In general, sphingolipids are a class of lipids essential for cell membranes structure but the past couple 
of decades have proved that SLs are not merely structural components of biological membranes, but 
also play other important roles in the cell life [Hakomori, et al. 1990]. 
In fact, as mentioned below, a large variety of specific SLs have been shown to modulate the cellular 
signaling pathway [Huwiler, Kolter, et al. 2000].  
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Figure 3 Chemical structure of ceramide and sphingosine. 
 
Biosynthesis 
 
Ceramide 
 
The starting point of the de novo sphingolipids biosynthesis is the ceramide formations in the ER. 
The first reaction consists in the condensation of the amino acid L-serine with palmitoyl-CoA to form 
3-ketosphinganine, catalyzed by the enzyme serine palmytoyl-transferase with the cofactor 
pyridoxal-phosphate.  
Subsequently, the 3-ketosphinganine, is reduced to D-erythro-sphinganine by 3-ketosphinganine 
reductase; the N-acyltransferase called ceramide synthase (in mammalian cells are known 6 different 
isoforms) [Levy and Futerman, et al. 2010] leads to the formation of dihydroceramide through the 
acylation of sphinganine [Rother, van Echten, et al. 1992]. Notably, ceramide synthase can also 
directly recycle the sphingosine derived from the ceramide catabolism [Shimeno, Soeda, et al. 1998].   
In the end, the major part of dihydroceramide is desaturated to ceramide thanks to the action of the 
enzyme dihydroceramide desaturase [Yamaji and Hanada, et al. 2015]. 
 
Sphingomyelin and Glycosphingolipids  
 
Sphingolipids biosynthesis is a “combinatorial process” driven by different transferases, able to use 
a lot of different precursor and intermediates to get the final products [Kolter, Proia, et al. 2002]; 
[Merrill, et al. 2002]. Ceramide is transported from the ER to the Golgi apparatus where the synthesis 
of complex sphingolipids occurs.   
Glycosyltransferases catalyze the reaction of transfer of a specific carbohydrate, from the sugar 
nucleotide (UDP-Glucose, UDP-Galactose) to a particular type of acceptor, as ceramide or the non-
reducing end of a carbohydrate chain attached to Cer [Prinetti, Loberto, et al. 2009].  
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The first step of glycosylation leads to the production of Glucosylceramide (GlcCer), its formation is 
catalyzed by a ceramide glucosyltransferase, called GlcCer synthase [Ichikawa and Hirabayashi, et 
al. 1998], located at the cytosolic side of the early Golgi membrane [Jeckel, Karrenbauer, et al. 1992]. 
The neo-synthetized GlcCer can follow two different ways: it can reach the plasma membrane or can 
be translocated to the luminal side of the Golgi. At this point, GlcCer represents the common 
precursor of the glycosphingolipids and it is further glycosylated by different glycosyltransferase to 
form more complex glycosphingolipids. 
The addition of a galactose residue from UDP-Gal to GlcCer, driven by a galactosyltransferase, leads 
to the formation of Lactosylceramide (LacCer).  
One of the major branch of metabolism of LacCer is the formation of ganglio series. The ganglio 
series is a class of GSLs characterized by the presence of sialic acid in their oligosaccharide chain. 
This class is particularly abundant in the cell of the central nervous system. 
The biosynthesis of the complex ganglioside occurs in the lumen of the Golgi apparatus by different 
glycosyltransferase. The GM3 synthase or sialyl-transferase provides to the sialylation of LacCer to 
form GM3. The other downstream metabolites in this pathway are formed by analogous reactions; 
GM3 is converted to GM2 by GM2 synthase or β-galactosamynil trasferase that transfer an N-
acetylgacatosamine to GM3, and GM2 is converted to GM1 by GM1b synthase.  
Neo-synthetized glycosphingolipids can reach the plasma membrane through the exocytotic vesicular 
traffic. 
On the other hand, the neo-synthesized ceramide, in Golgi apparatus, can be used for Sphingomyelin 
(SM) biosynthesis [Merrill and Jones, et al. 1990]. This reaction is catalyzed by SM synthase that is 
able to transfer phosphorylcoline from phosphatydilcolin to the hydroxyl group in position 1 of the 
spingoid base of ceramide, with the release of diacylglycerol.  
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Figure 4 The metabolism of SLs in the ER and Golgi apparatus.  
SLs synthesized in the ER are in greeen, and those synthetised in the Gogli apparatus are in orange [Lahiri and Futerman, et al. 
2007]. 
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Catabolism  
 
SLs metabolic homeostasis is obtained with the balancing of biosynthesis, degradation and recycling 
[Gault, Obeid, et al. 2010]. The central hub of SL anabolism is the vesicular transport of neo-
biosynthesized SLs from the endoplasmic reticulum and Golgi apparatus to the PM.  
On the other hand, metabolic turnover and degradation of plasma membrane sphingolipids are 
processes occurring in the lysosomes, the acidic compartment of the cells, by the presence of specific 
acidic hydrolases [Bartke and Hannun, et al. 2009]. The degradation process consists in the 
remodeling of the hydrophilic head, driven by the lysosomal glycosidase from the non-reducing end 
of the glycolipid substrates. The molecules resulting from the catabolism can leave the lysosomes and 
further be degraded or used again to form more complex structure [Carter, Hendry, et al. 1961].  
For example, during the ganglioside catabolism, GM1 is cleaved to GM2 by β-galactosidase. The 
resulting GM2 is than degraded to GM3 and N-acetyl-galactosamine through the action of β-
hexosaminidase A (HexA). The β-hexosaminidases are dimeric enzymes composed by two different 
subunit α and β. The different possible dimerization of their subunits leads to three different isoforms 
of the enzymes: Hex A, Hex B and Hex S [Kytzia and Sandhoff, et al. 1985]. 
GM3 is a substrate of sialidase Neu1 and Neu3, which leads to the formation of LacCer and sialic 
acid. Sialidases are glycohydrolases, which catalyze the removal of α-glycosidically linked sialic 
acid. Four different isoforms have been isolated from four different genes: Neu1, Neu2, Neu3 and 
Neu4 [Fingerhut, van der Horst, et al. 1992]. Neu1, Neu2, Neu3 are predominantly localized in the 
lysosomes, cytosol and plasma membrane respectively. Neu4 is present in mitochondria and 
endoplasmic reticulum. 
The degradation of LacCer is driven by β-galactocerebrosidase, which removes galactose obtaining 
GlcCer [Zschoche, Furst, et al. 1994].  
The GlcCer obtained by the reaction of β-galactocerebrosidase is further degraded to ceramide by the 
action of β-Glucosidase. GBA1 is the first enzyme identified as β-glucosidase and is lysosomal-
associated. GBA1 hydrolyze the glycosidic linkage of GlcCer, conduritol B Epoxide (CBE) inhibits 
this enzyme.  
On the other hand, SM is converted to Cer by sphingomyelinase (SMase). The eukaryotic cells are 
characterized by acid sphingomyelinase (aSMase) and neutral sphingomyelinase. The acid one is 
principally located in lysosome environment [Spence, et al. 1993].  
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Sphingolipid metabolism at the plasma membrane level 
 
Several process are responsible for the plasma membrane sphingolipids pattern and content. The 
principals are neo-biosynthesis in endoplasmic reticulum and Golgi, membrane turnover with final 
catabolism in lysosomes and membrane shedding.  
Moreover, some recent data reported that enzyme involved in the sphingolipids metabolism are able 
to modify the sphingolipids head group directly at the PM level [van Meer, Voelker, et al. 2008]. 
In fact, some of the same enzymes of the sphingolipids biosynthesis and catabolism are found to be 
associated with the cell surface. It has been observed that these enzymes are often available as a series 
Figure 5 Sphingolipid  catabolism  in  the  endo-lysosomal  compartment. 
Sphingolipids  catabolism  starts  from  invaginations  of  plasma  membrane  (PM)  portion  leading  to  the  formation  of  endocytic  
vesicles,  which  are  incorporated  in  the  primary lysosome. 
In  secondary  lysosome,  different  exoglycosidases  sequentially  cleave  off  the  sugar  residues  from  the  non-reducing  end of  
glycosphingolipids  (GSL)  producing  ceramide  (Cer). 
Cer  can  be  also  obtained  from  the  sphingomyelin  (SM)  catabolism  by  the  action  of  the  acidic-sphingomyelinase  (a-SMase). 
[Aureli, Schiumarini, et al. 2016] 
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of couple that catalyze the same reaction in opposite direction, contributing to the in situ changes of 
SL composition. This phenomenous leads to very important biological consequences, considering 
that could be instrumental to modulate cell function, with no involvement of the complex 
intracellular metabolic machinery.  
The couple of Sialidase/Sialyl trasferase represents the first example. The PM sialidase is Neu3 that 
preferentially hydrolyzed the α 2-3 external ketosidc linkages, being ineffective on inner sialic acid 
residues. The role of Neu3 is to modify the ganglioside composition at the cell surface 
Furthermore, it has been demonstrated also the presence of β-hexosaminidase A at the PM level, in 
combination with the β-hexosaminyl transferase. 
A particular case is represented by a PM-associate sphingomyelin synthase (SMS2) because is an 
enzyme genetically distinct from the Golgi’s one. SMS2 is present in combination with SMases. 
Three different SMases are available in eukaryotic cells: secreted SMase, acid SMase and neutral 
SMase. Only a particular isoform of neutral SMase, the nSMase2, works at the PM level.  
In addition, the β-galactosidase and the β-glucosidase acts at the cell surface. In particular two 
different β-glucosidase have been detected; GBA1 which is the same of lysosome and a non-
lysosomal β-glucosylceramidase GBA2.   
GBA2, like GBA1, is involved in the degradation of GlcCer to glucose and ceramide. It is considered 
a key enzyme in the glycosphingolipids homeostasis. GBA2 is not localized in the lysosome but is 
strongly associated with the plasma membrane, with five possible transmembrane domains. The most 
powerful inhibitor of GBA2 is N-5-adamantane-1-yl-methoxypentyl) deoxynojirimicin (AMP-
DNM), followed by miglustat [Boot, Verhoek, et al. 2007].  
GBA2 is ubiquitously distributed in several tissue and cell lines, in particular is expressed in brain, 
heart, skeletal muscle, kidney and placenta. In minor part is detectable in spleen, liver, small intestine 
and lung [Aureli, Loberto, et al. 2012, Aureli, Samarani, et al. 2016]. 
Of particular interest in the context of Cystic Fibrosis are the enzymes involved in the catabolism of 
sphingolipids, leading to the formation of ceramide and in the regulation of its content at the plasma 
membrane level, even considering the peculiar role of ceramide in the host defense and inflammation 
in CF lung disease. 
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Biochemical role of sphingolipids  
 
Several evidences in literature suggest that lipids are not only structural component of cell membrane 
but also fundamental actors of cell signaling and regulatory pathway [Hannun and Obeid, et al. 2008, 
Ohanian and Ohanian, et al. 2001].  
Ceramide, ceramide-1-phosphate, sphingosine, and sphingosine-1-phosphate have been shown to be 
involved in the regulation of a number of cellular events such as proliferation, differentiation, 
motility, growth, senescence, and apoptosis [Giussani, Tringali, et al. 2014]. Ceramide and S1P have 
been proposed to have opposite roles in these processes. The balance between ceramide and S1P, 
which are metabolically interconnected, determines the entrance into one or more of these pathways. 
Complex GSLs are also involved in cell physiology by acting as antigens, mediators of cell adhesion, 
binding agents for microbial toxins and growth factors, and modulators of signal transduction [Lahiri 
and Futerman, et al. 2007]. In particular, SLs together with cholesterol, saturated phospholipids and 
a specific pool of proteins organize macromolecular complex at the cell PM called lipids rafts. The 
lipids rafts theory was postulated in 1980s on the bases of the spontaneous lateral segregation of 
sphingolipids. This definition was subsequently modified to introduce the notion that lipid rafts 
correspond to membrane areas stabilized by the presence of cholesterol within a liquid-ordered phase 
[Sonnino and Prinetti, et al. 2013]. 
Nowadays, different studies reported in literature, describe membrane rafts as a dynamic nanoscale 
domain enriched in sphingolipids, cholesterol and ceramide, which play an important role in cell 
signal transduction [Simons and Sampaio, et al. 2011]. 
  
Figure 6 Schematic representation of sphingolipid metabolism occurring at the cell surface. [Aureli, Schiumarini, et al. 2016] 
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The forces that control the formation and dynamics of lipid rafts are not fully understood yet, but 
one of the important point is that the preponderance of saturated hydrocarbon chains in cell SLs 
allows cholesterol to be tightly interacted [Simons and Sampaio, et al. 2011]. 
Lipids rafts are mainly studied exploiting their resistance to solubilization by non-ionic detergent, 
like Triton X-100. Detergent-resistant membrane (DRM) complexes float to low density during 
sucrose gradient centrifugation and are enriched in rafts proteins and lipids, providing a simple means 
of identifying possible rafts component [Simons and Sampaio, et al. 2011]. 
Using this experimental approach it has been found that lipid rafts are characterized by heterogeneous 
protein and lipid content with a specific segregation of lipids formed by saturated and long 
hydrocarbon chains. Probably, in lipid rafts, SLs modulate the functional features of several 
membrane proteins by lateral interactions between SLs and plasma membrane protein, and by short-
range alterations of the physico-chemical properties of the protein membrane microenvironment. In 
fact, one of the most important property of lipid rafts is that they can include or exclude proteins to 
variable extents [van Meer and Lisman, et al. 2002].  
Proteins with rafts affinity include glycosylphosphatidylinositol (GPI)-anchored proteins, doubly 
acylated proteins, such as Src-family kinases or the α-subunits of heterotrimeric G proteins, 
cholesterol-linked and palmitoylated protein and transmembrane proteins.  
It is not yet clear why some transmembrane protein are included into lipid rafts, but some studies 
suggests the amino acids in the trasmembrane domains near the exoplasmic leaflet are critical as well 
as specific post-translational modification such as palmitoylations or myristoylations. In addition, a 
monomeric transmembrane protein may have a short residence time in rafts, but when the same 
protein is crosslinked or oligomerized, its affinity for rafts increase.  
The distribution of lipid rafts over the cell surface depends on the cell type. Generally, they are more 
abundant at the plasma membrane level, but are also present in the biosynthetic and endocytic 
pathway, as Golgi apparatus and endoplasmic reticulum. For example, in polarized epithelial cells, 
as epithelial bronchial cells, lipid rafts accumulate in the apical plasma membrane. 
A common theme is that the clustering of separate rafts exposes proteins to new membrane 
environments, enriched in specific enzyme, forming signaling platform, able to activate intracellular 
pathway like inflammatory response or apoptosis.  
Moreover, if receptor activation takes place in a lipid raft, the signaling complex is protected from 
non-rafts enzymes such as membrane phosphatase that otherwise could affect the signaling process. 
Generally, raft binding recruit proteins to a new-environment, where the phosphorylation state can be 
modified by local kinases and phosphatases, resulting in downstream signaling. Nervous system 
provides many examples of lipid rafts associated signaling. One example is represented by GDNF 
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signaling. The glial-cell-derived neurotrophic factor (GDNF) family of ligands is important for the 
development and maintenance of the nervous system. GDNF binds to a multicomponent receptor 
complex that is composed of GPI-linked GDNF receptors-α (GFR-α) and the trans-membrane 
tyrosine kinase, RET. The receptor subunit GFRα and RET are not associated with each other in the 
absence of ligand. However, after extracellular GDNF stimulation, RET moves into rafts, where it 
associates with GFRα in lipid rafts.  
One subclass of lipid rafts is found in cell surface invagination called caveolae involved in the 
regulation of several signaling processes including that mediated by the insulin receptor. 
IR is present in lipid rafts of normal adipocytes [Gustavsson, Parpal, et al. 1999] and localized in 
caveolae [Kabayama, Sato, et al. 2005], where the β-subunit of IR interacts with caveolin-1 through 
a binding motif recognizing the scaffold domain of caveolin-1 [Couet, Li, et al. 1997]. IR can form 
also a distinct complex with caveolin-1 and GM3 within lipid membrane domains [Kabayama, Sato, 
et al. 2007]. Interestingly, in 3T3-L1 adipocytes, the induction of insulin resistance by treatment with 
TNFα was accompanied by the upregulation of GM3 synthase, leading to an increase of cellular GM3 
[Tagami, Inokuchi Ji, et al. 2002] that accumulated in detergent-resistant membranes. In insulin 
resistance, the association between IR and GM3 was increased, while its association with caveolin-1 
was decreased, indicating that the excess amount of GM3 in lipid membrane domains leads to the 
displacement of IR from the complex with caveolin-1. This finding suggests that the regulation of IR/ 
caveolin-1 by GM3 could be responsible for the changes in insulin response in adipocytes. 
Many other signaling pathways work thanks to the presence of lipid raft suggesting that these 
structures are involved in a great variety of cellular functions and biological events.  
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Sphingolipids in Cystic Fibrosis 
 
Lung Sphingolipids 
 
A complex pattern of SLs characterises human lung tissue. Globosides, including globotetraosylCer 
and globotriaosylCer, are the major class of neutral glycolipids, followed by LacCer, GlcCer and 
tetrahexosylCer. In addition, among sialylated GLSs, in the lung are present fourteen different types 
of gangliosides. The most abundant is GM3 followed by GM1, disialo GD3, and 
trisialosyllactosylCer GT3. [Mansson, Mo, et al. 1986] 
SLs and their metabolism play an important role in lung development. For instance, the SL rheostat 
composed by Cer and S1P, promoting apoptosis and cell survival respectively, is required for growth 
of lung structure at all stages of lung development, as well as for pulmonary physiology preservation. 
More generally, the regulation of ceramide levels is important for lung homeostasis maintenance.  
Different studies reported the involvement of Cer in pulmonary infection, driven by a wide range of 
pathogens including Neisseria gonorrhoeae, Neisseria meningitidis, Staphylococcus aureus,  
Figure 7 Membrane model containing different DRM 
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Pseudomonas aeruginosa, Listeria monocytogenes, Salmonella typhimurium, Escherichia coli, 
mycobacteria, measles virus, rhinovirus, and sindbis virus [Seitz, Grassme, et al. 2015]. 
Cer is suitable to manage bacterial and viral infection thanks to its biophysical properties. Cer is 
characterized by high hydrophobicity, low amphiphilicity and is able to create small Cer-enriched 
membrane domain thanks to hydrophobic interaction. Indeed, is reported that, different stimuli, 
including bacterial infections, are responsible for the creation of Cer-enriched platforms [Teichgraber, 
Ulrich, et al. 2008]. 
 
Sphingolipids involvement in Cystic Fibrosis lung disease and infection 
 
Large amount of pro-inflammatory mediators, as interleukin-8 (IL-8), IL-6 and tumour necrosis factor 
(TNF)-α characterize the airways of CF patients. This condition cause the recruitment of neutrophils, 
unable to vanquish bacteria, leading to an amplification of inflammation and perpetual infection. 
Bacterial component bind different receptors, expressed on epithelial cell surface, such as Toll like 
receptors 2, 4 and 5. This binding activates a series of kinases that culminate in a nuclear translocation 
of transcription factor and expression of pro-inflammatory genes. 
Concerning the involvement of SLs in CF lung infection, some studies reported that GSLs of 
epithelial cell surface could operate as receptor for microorganism. In particular, for P. aeruginosa, 
it has been show that some clinically strains of this bacterium are able to bind asialo-GM1 and 
asialo-GM2. 
Conversely, the role of Cer in CF inflammation and infection is under debate. For instance, Guilbault 
and colleagues demonstrated that plasma of CF patients displays significantly low levels of several 
Cer species. In particular, they found in C57BL/6-CFTR mice an overall reduction of Cer level in 
lung, plasma, ileum and pancreas compared with WT mice [Guilbault, Wojewodka, et al. 2009]. 
Vilela and co-workers tried to elucidate the possible molecular mechanism involved in the reduction 
of ceramide in CF, using immortalized human respiratory tracheal epithelial cells.  
CF tracheal epithelial cells are characterized by a high level of glutathione that could decrease the 
intracellular Cer content through the inhibition of neutral sphingomyelinase. The increased activation 
of the pro-inflammatory transcription factor (NF)-kB, which is responsible for the abnormally high 
inflammatory response in CF, seems to be due to Cer deficiency. In fact, increased Cer levels, 
obtained by treatment of CFTR-deficient tracheal epithelial cells with fenretinide, results in an 
improved ability to control Pseudomonas aeruginosa infection [Guilbault, De Sanctis, et al. 2008, 
Vilela, Lands, et al. 2006] 
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On the other hand, Teichgraber and colleagues reported an age dependent accumulation of Cer in the 
respiratory tract of uninfected mutant mice lacking CFTR. To explain these findings they suggest 
that, the loss of CFTR induces an alkalinisation of intracellular vesicles that strongly reduces the 
activity of acid ceramidase, without substantial modification of acid sphingomyelinase activity 
[Teichgraber, Ulrich, et al. 2008]. This accumulation of Ceramide seems to be involved in the age-
dependent pulmonary inflammation and in the high susceptibility to P.aeruginosa infection. 
In contrast to Teichgraber and colleagues, Becker reported that inhibition of the acid 
sphingomyelinase reduces Cer levels and leads to an amelioration of the inflammatory response to 
P.aeruginosa [Becker, Tummler, et al. 2010]. These controversial data seems to be caused by the 
different mouse models used.  
Despite these contradictory results, Brodlie and colleagues described for the first time an increased 
Cer level in the lower airway epithelium of CF patients. In addition, they found an increased level of 
Cer in lung colonized by P.aeruginosa [Brodlie, McKean, et al. 2010] 
At this regard, ceramide itself is important for host defenses; in particular ceramide-enriched 
membrane platforms seems to be essential to clear bacteria and probably are involved in the mediation 
and control of the infection of several pathogens, like Pseudomonas aeruginosa. [Uhlig and Gulbins, 
et al. 2008, Yang and Uhlig, et al. 2011] 
These ceramide-enriched domains recruit some different receptors and signaling molecules, such as 
CD95, CD40 and CD14 important for the apoptosis or the activation of inflammatory response.For 
instance, Grassme in 2001 described how P.aeruginosa infection leads to the activation of ASMase 
and its translocation to the plasma membrane of normal epithelial cells. In this situation, ceramide, 
produced by SM hydrolysis, together with CD95 clusterization leads to P. aeruginosa internalization, 
induces apoptosis and regulates the cytokine response in the infected cells [Grassme, Becker, et al.]. 
These different studies suggests us that ceramide plays a very important role in the mechanism of 
host defense and inflammation in CF.  
Moreover, in addition to these data, the ceramide, which comes from catabolism of complex GSLs at 
the PM level, seems to plays an important role in the pro-inflammatory state of CF and in the 
inflammation caused by the infection of P.aeruginosa. In particular, the inhibition of GBA2 with 
miglustat, suggests its involvement in the production of ceramide at the cell surface of airway 
epithelial cells, after the infection caused by P. aeruginosa. Indeed, treatment of CF epithelial 
bronchial cells with miglustat reduce immune response after P. aeruginosa infection; more 
specifically Loberto and colleagues reported a down-regulation of chemokines, proinflammatory 
cytokines and the intercellular adhesion molecule-1 [Loberto, Tebon, et al. 2014] 
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In addition, the silencing of GBA2 with specific siRNA leads to a strong reduction of IL-8 secretion 
both in presence and in absence of P. aeruginosa infection in CF epithelial airway cells.  
All these findings open the possibility of targeting Cer metabolism as new therapeutic strategies for 
CF lung disease.  
 
Relationship between CFTR and sphingolipids 
 
Scientific literature describes CFTR as a transmembrane protein associated with lipid rats. Taking 
into account this characteristic, is reasonable to speculate that the stabilization of the protein or the 
modulation of its function is driven by SLs interaction.  
For instance, Hamai et al reported a relationship between CFTR expression and SL synthesis. Mutated 
CFTR or decreased expression leads to an increased SL synthesis and as consequence, an increase 
content of SM, sphingosine and sphinganine at the PM level. In addition, it was observed that the 
lack of CFTR causes an alteration of PM Ceramide composition; in particular, there is an increased 
content of long-chain Cer species. The increased Cer production can be interpreted as a cellular 
response to the plasma membrane destabilization. In this context, even the SL synthesis could be a 
compensatory mechanism directed to increase membrane stability [Hamai, Keyserman, et al. 2009]. 
Another example of this process is represented by the study of Itokazu and colleagues, which 
described a direct correlation between PM levels of ganglioside GM1 and CFTR expression. CFTR-
silenced human airway cells have a decreased content of GM1 and a depressed β-integrin signalling, 
resulting in a reduction of cell motility. They demonstrated that the addition of GM1 to this type 
ofcells, partially restores cell migration. In addition, they demonstrated that the recovery of CFTR in 
CFTR-silenced cells significantly increases GM1 levels. On the other hand, the pharmacological 
inhibition of CFTR in normal cells, decreases GM1 content [Itokazu, Pagano, et al. 2014]. These data 
have implications for the CF pathology, where altered SL levels in CF airway epithelial cells is 
probably involved in a diminished process of wound repair.  
Ramu and colleagues published data related to the regulation of CFTR function by the PM micro-
enviroment. They described that the inhibition of CFTR current is caused by the formation of 
ceramide from SM hydrolysis. The clusterization of CFTR in membrane areas rich in ceramide makes 
more difficult the channel activation by phosphorylation of regulatory domain [Ramu, Xu, et al. 
2007]. 
This situation becomes worse with the presence of some pathogens, like Pseudomonas aeruginosa, 
which has a SMase activity that hydrolyses SM in situ, leading to the formation of Cer. The reduced  
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CFTR activity caused by P. aerugionosa, is accompanied also by an impaired mucociliary clearance 
and, as consequence, a decreased ability to clear bacteria [Stonehouse, Cota-Gomez, et al. 2002]. 
Ceramide produced by bacterial SMase has an effect on CFTR stabilization even influencing the 
regulation of a scaffolding protein ERM (ezrin/radixin/moesin). The ERM complex regulates 
cytoskeletal plasma membrane interaction.  
In particular, Ezrin is important for the CFTR activation because acts as a PKA-anchoring protein, 
recruiting a PKA to the proximity of CFTR, leading to its activation. Some data reported that ceramide 
promotes ERM dephosphorylation and, as consequence its inactivation, through a protein 
phosphatases.  
Although several findings clearly demonstrated that CF pulmonary disease is characterized by altered 
SL metabolism, unfortunately, the direct involvement of SLs in the pathogenesis of CF lung disease 
is still unclear. 
Future progress in understanding the critical role of SLs in the pathophysiology of Cystic Fibrosis 
could open new perspectives for the development of alternative SL-based therapeutic strategies to 
reduce the inflammatory response as well as to rescue or increase the CFTR function at the cell 
surface. 
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Aim 
 
Airway obstruction, infection and inflammation are the most severe pathophysiologic feature of CF 
lung disease and for this reason, are direct target of many current and candidate therapies and 
treatment for this pathology. 
There are many therapies available to manage airway infection, inflammation and mucus alteration. 
For instance, the drugs suitable to treat bacterial infection are tobramycin, fluroquinolone and 
different inhaled antibiotic combination [Cantin, Hartl, et al. 2015]. Considering anti-inflammatory 
therapies, Ibuprofen and corticosteroids are the only effective anti-inflammatory drug, recommended 
as a beneficial therapy for patient from 7 to 18 years of age, even though limited efficacy or the 
occurrence of severe side effects [Hoffman and Ramsey, et al, Konstan, Schluchter, et al. 2007].  
Hence, the identification and development of novel and more potent anti-inflammatory drugs for CF 
airway disease remains a priority. SLs metabolism seems to be a potential new target for therapeutic 
intervention. In particular, Ceramide seems to be involved in the process of infection and 
inflammation of CF. As mentioned in detail in the introduction, Becker and colleagues reported that 
inhalation of acid sphingomyelinase inhibitors, such as amitriptyline, trimipramine, desipramine, 
fluoxetine or sertraline reduce pulmonary inflammation and prevent lung infection in CF mice 
[Becker, Riethmuller, et al.]. On the same frame of work, Nahrlich and colleagues conducted a phase 
IIb randomized, double bind, placebo controlled study, to test an in vivo beneficial effect of 
amitriptyline. They reported that this drug is safe and it reduces ceramide in lung of CF patients 
[Nahrlich, Mainz, et al. 2013]. In addition, recent findings reported by Caretti and colleagues 
demonstrated that the use of myriocin, an inhibitors of the ceramide de novo synthesis, leads to reduce 
bacterial infection [Caretti, Bragonzi, et al. 2013]. 
On the other hand, emerging and promising data derive from the study related to in situ plasma 
membrane catabolism of complex glycosphingolipids and the inflammatory response to P. 
aeruginosa. The inhibition of GBA2 by iminosugars such as Miglustat shows an anti-inflammatory 
effect in vitro by reducing P.aeruginosa induced immunoreactive ceramide levels [Dechecchi, 
Nicolis, et al. 2011]. 
Taking into account the increasing interest on the SL metabolism as target of CF anti-inflammatory 
therapy and considering the important results correlated to the use of Miglustat, I explored the 
potential involvement of GBA2 in the ceramide-mediated signaling process, following P.aeruginosa 
infection of CF human epithelial bronchial cells. 
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The study is based on the preliminary evidence that suggests the link between GLS catabolism leading 
to the PM cer production, and the inflammatory response in CF, even after the infection with 
Pseudomonas aeruginosa.  
More in detail, preliminary results demonstrate that both the inhibition of GBA2 activity by miglustat 
and the down-regulation of its expression are associated with a significant reduction of IL-8, in CF 
human airways epithelial cells, infected with P. aeruginosa. Moreover, GBA2 knockdown results in 
a reduction of the intrinsic pro-inflammatory state of these cells, since it was observed a reduction of 
IL-8 basal level in not infected cells.  
However, no data are available regarding the mechanistic link between the involvement of GBA2 and 
the inflammation state characteristic of CF.  
For this reason in this thesis work, I focused my attention mainly on the involvement of the PM 
glycohydrolases in the CF inflammation process, with particular interest for GBA2, which seems to 
play an important regulatory role. I studied the possible correlation among the ceramide production 
at the PM level through the action of the PM glycohydrolases, and IL-8 release and expression. 
Considering all these aspects, the specific aims of my PhD project were:  
 
1. The Identification of the molecular mechanism linking the PM glycohydrolases and the 
inflammation response in CF lung disease:  
First, I characterized CF and non-CF epithelial bronchial cells in terms of glycohydrolases activity 
and SLs pattern. I compared the different behavior of glycohydrolases and changes in SLs 
composition in CF and non-CF cells after infection with Pseudomonas aeruginosa. 
Moreover, I studied the PM microenvironment of the glycohydrolase by lipid rafts isolation, with 
particular interest on GBA2, after the infection of Pseudomonas aeruginosa. I also investigated the 
effect of the bacterial infection on the plasma membrane localization of the different glycohydrolases.  
 
2. Development and characterization of a Nanoparticles-based siRNA-GBA2 delivering system. 
The second objective of my work was based on the important findings that shows that the silencing 
of GBA2 leads to a reduction of the pro-inflammatory status of CF bronchial epithelial cell, as well 
as reduction of inflammatory response after bacterial infection. This evidence suggests the possibility 
to work on the down-regulation of GBA2 for the development of a new therapeutic option. With this 
purpose, I studied a new strategy to delivery siRNA in CF epithelial bronchial cell in order to knock 
down GBA2.  
More in details, I first identified the best siRNA sequences giving the highest GBA2 down-regulation 
in term of expression and activity. Subsequently, I developed, in collaboration with a group of  
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physicist, a high efficient multicomponent nanoparticle, useful for the delivering of siRNA targeting 
GBA2.  
After the nanoparticles assembly, we proceed with a physical characterization by Dynamic light 
scattering. Subsequently, we evaluated the transfection potential in CF bronchial epithelial cells. 
Finally, we tested the toxicity of the assembled nanoparticles by a cell proliferation assay and we 
evaluated the expression of biochemical marker of cell damage.  
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Materials and Methods 
 
Cell models 
 
CuFi-1: CuFi-1 cells line are a generous gift of A. Klingelhuts, Pkarp and J Zbaner, University of 
Iowa, Iowa city. [Zabner, Karp, et al. 2003] 
CuFi-1 are Cystic Fibrosis human epithelial bronchial cells characterized by the homozygous 
mutation ΔF508/ΔF508, growth and propagated into normal plastic flasks, pre-coated with collagen 
(Collagen IV from human placenta- Sigma Aldrich). 
10 mg of Collagen IV was dissolved in 16,6 ml di H2O and 33,3 µl of acetic acid, and left at 37°C 
under gentle shacking until the complete dissolution.  
I used as culture medium; “Bronchial Epithelial Basal Medium” (BEBM) supplemented with specific 
factors: 5 μg/mL insulin, 0.5 ng/mL hEGF, 0.5 μg/mL hydrocortisone, 0.5 μg/mL epinephrine, 50 
μg/mL amphotericin B, 10 μg/mL transferrin, 6.5 ng/mL triiodothyronin, and 0.13 mg/mL bovine 
pituitary extract (all supplied by Lonza; singleQuot Kit Lonza) to obtain Bronchial Epithelial growth 
medium (BEGM). To BEGM was added glutamine (2mM) and Penicillin/Streptomycin (100 u/ml 
and 100 µg/ml respectively). The cells were cultured as monolayer in a humidified atmosphere at 
37°C and 5% CO2. 
NuLi-1: NuLi-1 are wild type (non-CF) human epithelial bronchial cells, cultured in the same way of 
CuFi-1 cells as previously described by Dechecchi and Colleagues[Dechecchi, Nicolis, et al. 2008].  
 
Bacterial strain  
 
For infections experiments I used heat killed Pseudomonas aeruginosa strain PAO-1, kindly provided 
by A. Prince (Columbia University, New York).  
PAO-1 was grown in a trypticase soy broth (TSB) or agar (TSA) as described by Dechecchi and 
colleagues [Dechecchi, Nicolis, et al. 2008]. The organism was killed by heating to 65°C for 30 
minutes.  
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Bacterial infection and evaluation of the inflammatory response in vitro 
 
Cells were infected for 4 hours with a PAO-1 concentration of 100 CFU/cells.  
The inflammatory response to PAO1-1 infection was studied at the transcriptional level by measuring 
IL-8 chemokine expression as described by Dechecchi and colleagues. [Dechecchi, Nicolis, et al. 
2011] Briefly, 50 ng of cDNA was amplified by the Platinum SYBR Green qPCR Super MixUDG 
(Invitrogen, Carlsbad, CA, USA) in a 1X final concentration in a total volume of 25 μl reaction. The 
target genes and the respective calibrator genes were amplified in separate tubes. 
Amplification conditions were: an initial denaturation/activation step of 95°C for 2 min, followed by 
50 repeats of 95°C for 15 s and 60°C for 30 s. Single Tube qRT-PCR was performed according to the 
comparative CT method and in duplicate [Dechecchi, Nicolis, et al. 2011]. 
 
Cell sphingolipid labelling with [1-3H]-sphingosine 
 
The sphingolipids analyses was performed through a sensitive method based on the use of [1-3H]-
sphingosine, as isotopic labelled sphingolipids precursor. This method allows the quick and sensitive 
screening of sphingolipids patterns and the quantitative evaluation of sphingolipids turnover in 
cultured cells.  
The [1-3H]-sphingosine was administered as tracer in non-bioactive concentration for two hours 
(pulse) in order to allow the steady state metabolic labelling of all cell sphingolipids [Loberto, Prioni, 
et al. 2005]. Briefly, [1-3H]-sphingosine dissolved in methanol was transferred into a sterile glass 
tube and dried under a nitrogen stream, and [1-3H]-sphingosine was solubilized in an appropriate 
volume of pre-warmed (37° C) medium (BEGM) to obtain a concentration of 0,3 nM. 
The correct solubilisation was verified by measuring the number of dpm in a aliquot of medium. 
After 2 hours of incubation (pulse) the medium was removed and cell were incubated for 48 h (chase) 
in fresh culture medium without the radioactive sphingosine. After chase, cells were collected and 
were used to perform the analysis of radioactive lipid or for DRM preparation. 
  
Biotinylation 
 
After the treatment of cells with PAO-1 or PBS for control sample, cells were incubated with 0.25 
mg/ml of sulfo-NHS-biotin in PBS, pH 7.4 (5 ml/flask) for 30 minutes at 4°C.  
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The sulfo-NHS-biotin in excess was quenched by washing each flask with 5 ml of glycine (100 mM) 
in PBS. Thanks to these experimental conditions, the biotinylation is restricted to the cells surface  
and the internalization of the biotin derivative does not occur [Chigorno, Valsecchi, et al. 1990] 
[Aureli, Prioni, et al. 2010]. 
 
Isolation of detergent resistance membrane (DRM) fractions  
 
DRM were prepared by ultracentrifugation on discontinuous sucrose gradient of cells subjected to 
homogenization with 1% Triton X-100 as previously described by Aureli and colleagues. [Aureli, 
Prioni, et al. 2010] 
Briefly, after centrifugation at 270xg for 10 minutes, cell pellet was lysed in 1.2 ml of 1% Triton X-
100 in 10 mM TNEV buffer (TrisHCl 10 mM, NaCl 150 mM, EDTA 5 mM, pH 7.5 ) in presence of 
1 mM Na3VO4, 1 mM PMSF, and 75 mU/ml aprotinin, and Dounce homogenized (11 strokes, tight).  
Cell lysate (2 mg of cell protein/ml) was centrifuged 5 min at 1300xg to remove nuclei and cellular 
debris and the post nuclear supernatant (PNS) was removed and transferred in a different tube.  
1ml of PNS was mixed with 1 ml of 85% sucrose (w/v) in TNEV Buffer (TrisHCl 10 mM,  NaCl 150 
mM, EDTA 5mM and pH 7.5) and 1 mM Na3VO4, placed at the bottom of a discontinuous sucrose 
gradient (30% and 5%), and centrifuged for 17 hr at 200,000xg at 4°C.  
After ultracentrifugation, eleven fractions were collected, starting from the top of the tube. The light-
scattering band, corresponding to the DRM fraction, was located at the interface between 5% and 
30% sucrose, corresponding to fraction 4 or 5. Equal amounts of the low-density fractions (4 and 5) 
were mixed to obtain the DRM fraction, whereas equal amounts of the high-density fractions (10 and 
11) were mixed to obtain the HD fraction. DRM and HD fractions were used for the lipid analyses 
and for hydrolases assays. The entire procedure was performed at 0-4°C on ice immersion. For the 
lipid analyses, low-density (4 and 5) and high-density fractions (10 and 11) were dialyzed and 
lyophilised.  
The obtained samples were subjected to lipid extraction with CHCl3/CH3OH/H2O. The total lipid 
extract was analysed by thin layer chromatography (HPTLC). Aliquots of the total lipid extracts from 
DRM and HD fractions were subjected to a two-phase partitioning as described below. 
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Immunoprecipitation 
 
In order to isolate DRM, belonging only to plasma membrane, the DRM fraction was 
immunoprecipitated with streptavidin-coupled magnetic beads (Thermo-Fisher), which recognize the 
biotinylated protein with high affinity. The magnetic beads were washed twice with PBS and the 
mixture of DRM and beads were stirred overnight at 4°C. The immunoprecipitated was recovered by 
centrifugation according to manufactures instruction. Under these conditions (domain-preserving 
conditions), we preserved the organization of lipid domains [Aureli, Prioni, et al. 2010]. 
 
Sphingolipid analysis 
 
Cells or DRM and HD fractions were lyophilized and subjected to lipid extraction and sphingolipids 
analyses.  
Total lipids from lyophilized cells were extracted with CHCl3/CH3OH/H2O 20:10:1 by vol, followed 
by a second extraction with CHCl3/CH3OH 2:1 by vol. The total lipid extracts were subjected to a 
two-phase partitioning by adding 20% water to the lipid extract. The radioactivity associated with the 
total lipid extract, the aqueous and the organic phases were evaluated by liquid scintillations using 
beta-counter system.  
[3H]SLs of total extracts and organic phases were separated by high performance thin layer 
chromatography (HPTLC) using the solvent system CHCl3/CH3OH/H2O 110:40:6 by vol, and those 
of aqueous phases with CHCl3/CH3OH/0.2% aqueous CaCl2, 50:42:11 by vol. [
3H]-SLs were 
identified by digital autoradiography using TRacer system (Biospace Lab) and quantified by M3vision 
software. The lipid identification was performed using purified radioactive standards [Scandroglio, 
Venkata, et al. 2008].  
 
Generation of GBA2-GFP overexpressing epithelial bronchial cell line 
 
To generate a CuFi-1 and NuLi-1 cell line, overexpressing GBA2 tagged with GFP, the OriGene 
Company cloned the cDNA into a lentiviral vector (pLenti-GBA2-GFP). A lentiviral vector 
containing only GFP (pLenty-GFP) was used to generate Mock cells. Viral particles were generated 
by transfecting 3 µg of pLenti-GBA2-GFP or pLenti-GFP vectors and 9 µg of packaging vector mix 
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(coding for Gag, Pol Tat, Rev and VSVG ) in 293FT cells by LipofectamineTM 2000 Reagent 
(Invitrogen).  
Supernatant media were collected 48h after transfection, filtered through a 0.4 µm membrane, and 
used to infect CuFi-1 and NuLi-1 cells. [The viral titers were determined by transducing the 293FT  
cells with 10 fold serial dilutions of the lentiviruses supernatant (10-2-10-6 dilutions) or not 
transduced]. 
At 48 h after transduction, cells were plated under puromycin selection (5 µg/mL). After 10 days of 
selection, the cells were stained with crystal violet and were counted. CuFi-1 and NuLi-1 cells were 
infected with 1 ml of each lentivirus stock. After 1 day, medium was replaced with fresh medium 
containing the specific antibiotic to select the positive clones. To obtain the constitutive clones the 
transduced cells were selected with 5 µg/ml of puromycin and after 3 weeks of selection, colonies 
were separated and expanded.  
Clones obtained were analyzed morphologically for the GBA2 tagged with GFP or GFP expression 
by confocal microscopy using cells fixed with paraformaldehyde (2% in PBS) for 20 min. 
 
Enzymatic activity associated with cell plasma membrane 
 
The assay, used during my experiments, allows the detection of the plasma membrane associated 
activity directly on living cells, using fluorigenic substrates. This method is based on the observation 
that the fluorigenic substrates commonly used for the in vitro assay of glycohydrolase activities are 
not taken up by living cells [Aureli, Loberto, et al. 2011]. 
In fact, under the appropriate experimental conditions, it is not possible to observe any fluorescence 
associated with cells. Moreover, the artificial substrates did not undergo to spontaneous hydrolysis or 
to hydrolysis driven by secreted enzymes. Thus, their hydrolysis under these experimental conditions 
is due exclusively to the PM-associated enzymatic activities [Aureli, Masilamani, et al. 2009].  
PM associated activities of β-Galactosidase (β-Gal), β-Glucosidase GBA1, β-Glucosidase GBA2, β-
Hexosaminidase (β-Hex) and sphingomyelinase (SMase) activities were determined on living cells, 
plated in 96-well microplate at density of 20000 cells/well, by a high throughput assay.  
For GBA1 and GBA2 assays, cells were pre-incubated for 30 minutes at room temperature with 5 
nM AMP-dNM [adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl) 
deoxynojirimycin] and 1 mM CBE (Sigma) in DMEM-F12, respectively [Overkleeft, Renkema, et 
al. 1998].  
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β- Gal, β-Hex and β-Glucosidase activities were assayed using the artificial substrates 4-134 
methylumbelliferyl-β-D-galactopyranoside (MUB-Gal), MUG and 4-methylumbelliferyl-β-D-
glucopyranoside (MUB-Glc) solubilized in DMEM-F12 without phenol red at pH 6 at the final 
concentrations of 250 µM, 2 mM and 6 mM respectively. SMase activity was assayed using the 
artificial substrates 6-hexadecanoylamino-4-methylumbelliferyl-phosphoryl-choline (H-MUB-PC) 
solubilized in the same DMEM-F12 at the final concentration of 100 µM. At different time points 
aliquots of medium (10 µl) were analyzed by fluorimeter in a microplate reader (Victor, Perkin Elmer) 
(MUB: λex: 355 nm /λem: 460nm; H-MUB: λex: 405 nm /λem: 460nm) after adding 190 µl of 0.25 
M glycine (containing 0,3% Triton X-100 for SMase assay), pH 10.7. 
Standards free MUB and H-MUB were used to establish the calibration curves in order to quantify 
the substrates hydrolysis. 
The enzymatic activity was expressed as pmol of products on mg protein per hour.  
 
Enzymatic activity associated with cell lysate or sucrose gradient fractions 
 
The enzymatic activities of β-Glucosidase GBA1 and GBA2, β-Galactosidase, β-Hexosaminidase, 
and SMase in the total cell lysates were determined using fluorigenic substrates as described by Aureli 
and colleagues, with few modifications [Aureli, Gritti, et al. 2012, Gatti, Lombardo, et al. 1985] 
Briefly, cells were washed twice with PBS, were harvested and suspended in water in the presence 
of a protease inhibitor cocktail (Sigma-Aldrich). Total cell protein were evaluated by DC protein 
assay (Biorad) according to manufacturer instruction.  
Equal amount of cell proteins were transferred into a 96-well microplate and the assay was performed 
three-fold in replicate. MUB-Glc was solubilized in McIlvaine buffer (pH 6) at the concentration of 
24 mM.  MUB-Gal, MUG and H-MUB-PC was solubilized in McIlvaine buffer (pH 5.2) at the 
concentration of 250 µM, 2 mM and 100 µM respectively.  
For GBA1 and GBA2 assays, cells were pre-incubated for 30 minutes at room temperature with 5 
nM AMP-dNM [adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl) 
deoxynojirimycin] and 1 mM CBE (Sigma). 
The reaction mixtures were incubated at 37°C under gentle shaking. After transferring 10 μl of the 
reaction mixtures to a 96 black well microplate and adding 190 μl of glycine (0.25M, pH 10.7), the 
obtained fluorescence was detected at different time points by a Victor microplate reader (Perkin 
Elmer) 
Standards free MUB and H-MUB were used to establish the calibration curves in order to quantify 
the substrates hydrolysis. 
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The enzymatic activity was expressed as pmol of product on mg protein per hour.  
The enzymatic activity associate with the sucrose gradient fractions were expressed as pmol of 
product on volume of fraction per hour. 
 
Western blot analyses 
 
Proteins from cell homogenates or gradient fraction sample were separated by SDS-PAGE gels and 
transferred onto PVDF membrane by electroblotting. Gel was made at 10% of acrilammide. After 
blocking with 5% skim milk in TBS-T buffer, membranes were incubated overnight at 4°C with 
primary antibodies. Caspase 8, NF-kB, P-FADD, RIP, Caspase-3, p62 (Cell Signaling), calnexin 
(BD), LC3b (Sigma) were used at the final dilution of 1:1000. GAPDH (Sigma) was used at the 
dilution of 1:7000.  
After washing, the reaction with secondary antibodies (horseradish peroxidase-conjugated 
antibodies) was performed and enhanced chemiluminescencce detection (Pierce) was conducted as 
described in the manufacture instruction. GAPDH and calnexin were used as control.  
For immunoprecipitation samples, I used HRP-conjugated streptavidin in order to visualize the 
biotinylated proteins. The data acquisition was performed using a Mini HD9 (UviTec, Cambridge) 
and analyzed by Nine Alliance mini HD9 software.  
 
GBA2 silencing 
 
To perform silencing experiments of GBA2 gene, I selected six different siRNA sequences, purchased 
form Quiagen, targeting different positions within GBA2 mRNA.  
CuFi-1 cells were transiently transfected with siRNA anti-GBA2 or scrambled duplexes, complexed 
with cationic liposomes Lipofectamine 2000.  
The silencing efficiency was evaluated by enzymatic activity and mRNA expression at different time 
points.  
 
Cationic liposomes 
 
The binary mixture DC-Chol/DOPE, at a molar ratio Φ = (neutral lipid/total lipid) = 0.5 were prepared 
by mixing appropriate amounts of the lipids dissolved in chloroform. The solvent was removed under 
 
35 Materials and Methods 
gentle stream of nitrogen and then kept under vacuum for 1 hour to ensure complete solvent removal. 
The lipid film were hydrated with water at the concentration of 20 mg/ml. Lipid mixture was then 
treated until clarity in an ultrasonic bath and stored at room temperature for 1 day, to attain liposome 
stability. 
  
Cationic lipoplexes  
 
23 bp DNA was used as a mimic of 23 bp siRNA in order to build nanovectors with the same structural 
feature as those of the cell delivered vectors, but in large amount to perform X-ray characterization. 
DNA was solubilized in ultrapure water (5mg/ml). DNA fragments of 23 base pairs were used.  
Self-assembled DC-Chol/DOPE-DNA lipoplexes were prepared at the weight ratio ρ = cationic 
lipid/DNA = 5,  by proper drop-addition of the DNA solution to CL dispersion and incubated at room 
temperature for 20 minutes. The solution did not show any microscopic precipitation.  
 
Nanoparticle system  
 
A 23 bp DNA, as mimic of 23 bp siRNA, was pre-complexed with protamine by dissolving protamine 
sulfate in Milli-Q water (2.5 mg/ml), then added dropwise to an equal volume of DNA solutions 
under gentle shaking, with a weight ratio (protamine/DNA) Rw = 0.5. At this ratio protamine/DNA 
complexes are negatively charged thus suitable to interact with cationic liposome. The 
protamine/DNA solution was then mixed with the cationic liposomes at weight ratio ρ = cationic 
lipid/DNA = 5. Self-assembled DC-Chol/DOPE-protamine/DNA NP were kept at room temperature 
for 20 minutes in order to stabilize it. The solution did not show any macroscopic precipitation.  
 
NP for in vitro delivery of siRNA 
 
Liposomes for nanovector preparation were prepared at 0.1mg/ml DC-Chol concentration and at lipid 
molar ratio Φ = (neutral lipid/total lipid) = 0.5, as above. For each transfection-solution, 50 µl 
protamine/siRNA solution containing 100pmol of siRNA were prepared in weight ratio Rw=0.5. 
After 20 minutes equilibration time, protamine/siRNA solution was properly drop-added to the 
liposome solution fulfilling the weight ratio ρ = cationic lipid/siRNA = 5 [Zhang, Li, et al. 2010]. 
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Dynamic light scattering  
 
Dynamic Laser Light Scattering measurements were carried out on a home designed apparatus. 
Sample were properly diluted, with filtered water (polycarbonate membranes, 0.2 µm pore size) 
inorder to avoid multiple scattering. The correlation functions of the scattered intensity were 
measured at T = 25°C. Data were collected at 90 ° scattering angle, and analyzed with Cumulants 
Method giving the particle average size and polydispersity index. The weigh-average size distribution 
was obtained with the CONTIN analysis.  
 
Statistical analysis 
 
All the experiments were performed in triplicate and statistical significance was determined by 
Student-Neumann-Keuls post hoc test (comparison between two groups) and for more than two 
groups by one-way or two-way ANOVA (followed by Turkey or Dunnett Neueman-Keuls on 
Bonferroni post test), with p <0.05 as significant. 
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Results 
 
Effect of bacterial infection on the plasma membrane composition of CF 
epithelial bronchial cells 
 
Sphingolipids characterization and evaluation of hydrolases activity of CF and non-CF 
epithelial bronchial cell lines 
 
In order to study the involvement of ceramide pathway in the intrinsic pro-inflammatory state of CF 
and to investigate the role of ceramide during bacterial infection, I chose the commonly used CF 
(CuFi-1) and non-CF (NuLi-1), cell models of human epithelial bronchial cells. 
CuFi-1 and NuLi-1 cell lines derive from the same bronchial district and they were cultured in the 
same conditions.  
First, I analyzed the SLs composition of these cell lines by feeding the cells with the radioactive 
precursor [1-3H]-sphingosine in conditions that allow the metabolic labeling of the cellular 
sphingolipids at the steady state. Subsequently I separated the single [3H]-lipids contained in the total 
lipid extract through high performance thin layer chromatography (HPTLC).  
The digital autoradiography of HPTLC (figure 8), shows a similar SL pattern between CuFi-1 and 
NuLi-1 cells even with some differences. In particular, CuFi-1 cells are characterized by a major 
content of Cer and GlcCer, whereas the level of SM and ganglioside GM3 are lower, if compared to 
NuLi-1 cells. 
Interestingly, the data related to the Cer content agree with the data found in the lungs of CF patients. 
In fact, Brodlie and colleagues described for the first time an increased Cer level in the lower airway 
epithelium of CF patients [Brodlie M, McKean MC, et al. 2010]. These findings and the data reported 
in literature, support the use of CuFi-1 and NuLi-1 cells to study the SL involvement in the 
pathophysiology of CF. 
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In addition, the shift from complex sphingolipids, such as GM3 and SM, to GlcCer and Cer suggests 
a major activation of the SL catabolic pathway in CuFi-1 cells.  
Since the two main cellular district involved in the SLs catabolism are lysosomes and the cell plasma 
membrane, first I measured the enzymatic activity of the main SL hydrolases associated with 
lysosome. As shown in figure 9, I found that, for all the tested hydrolases, NuLi-1 cells show higher 
activity if compared to CuFi-1 cells. More in detail, the activity of β-glucosidase GBA1, β-
galactosidase (β-gal) and sphingomyelinase (SMase) is double in NuLi-1 in respect of CuFi-1. 
Whereas the activity of GBA2 is only 20% higher in NuLi-1, compared to CuFi-1 cells.   
  
Figure 8 Sphingolipid composition of CuFi-1 and NuLi-1 cell lines.  
Left: Autoradiography of HPTLC of radioactive sphingolipids obtained from total lipid extract of CuFi-1 and NuLi-1 cells. 
Each sample was loaded at parity of radioactivity.  
Right: Semi-quantitative graph of sphingolipids species. The sphingolipids are represented as percentage of radioactivity. 
Cer: ceramide; GlcCer: glucosylceramide; PE: phosphatidylethanolamine; SM: sphingomyelin  
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Subsequently, I measured the enzymatic activity of hydrolases associated with the cell plasma 
membrane. Interestingly I obtained opposite results with respect to the total cell associate hydrolases. 
In fact, the pathological CuFi-1 cells are characterized by a double activity of the PM hydrolases if 
compared to the healthy NuLi-1 cells (figure 10). In particular, GBA2 is more than two times higher 
with respect to NuLi-1 cells.  
These data suggest that the high level of ceramide of CuFi-1 cells, could be due to the increased 
hydrolysis of SLs, triggered directly at the cell plasma membrane level, by the in-situ action of the 
resident glycohydrolases.  
These data agree with some data previously reported by Loberto and colleagues [Loberto, Tebon et 
al. 2014] on the production of Cer at the cell surface, which is involved in the activation of the 
inflammatory response after bacterial infection.  
Figure 9 Hydrolases activity associate with total cell lysate of CuFi-1 and NuLi-1 cells. 
The measurement of the hydrolases activity was conducted on cell lysate using an in vitro assay based on artificial fluorigenic substrates.  
The enzymatic activity is expressed as pmoles of products on mg of proteins per hour. 
GBA1: β-Glucosidase 1; GBA2: β-Glucosidase 2; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase 
*p<0.05 vs NuLi-1  
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Effect of Pseudomonas aeruginosa infection on the sphingolipids composition of  
CuFi-1 and NuLi-1 cell lines 
 
Several lines of evidence suggest that ceramide accumulation correlates with the age-depended hyper- 
susceptibility of CF patients to bacterial infection. One of the main debatable aspect is related to the 
direct involvement of infection in the production of ceramide. In order to shed light on this aspect, I 
investigated the effect of Pseudomonas aeruginosa, the most severe pathogens in CF, to part of the 
molecular mechanisms involved in the modulation of ceramide level in CuFi-1 and NuLi-1 cell lines. 
In these experiments, cellular SLs were metabolically labelled at the steady state using [1-3H]-
sphingosine and the two cell lines were infected with heat killed PAO-1 for 4 hours. I found that the 
two cell lines were characterized by the same incorporation of radioactive sphingosine. I separated 
the lipids contained in the total lipid extract by HPTLC and the radioactive lipids were visualized by 
digital autoradiography. 
  
Figure 10 Hydrolases activity associate with the cell plasma membrane of CuFi-1 and NuLi-1 cell line. 
The measurement of the plasma membrane hydrolases activity was conducted on living cells, using artificial fluorigenic substrates. 
The enzymatic activity is expressed as pmoles of products, on 106 cells per hour. 
GBA1: β-Glucosidase1 GBA2: β-Glucosidase 2 β-Gal: β-Galactosidase β-Hex: β-Hexosaminidase   
*p<0.05 vs NuLi-1 
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The obtained results (figure 11) show that the content of Cer and GlcCer in infected CuFi-1 cells is 
significantly increased if compared with not infected cells. On the other hand, in NuLi-1 cells, PAO-
1 infection causes only a slight increase of Cer. 
 
 
 
 
 
 
 
 
Effect of Pseudomonas aeruginosa infection on hydrolases activity. 
 
The previously results show that Pseudomonas aeruginosa is able to cause significant changes in the 
SL composition. It has been recently demonstrated that the inhibition of GBA2 in CF human 
bronchial epithelial cells results in an important reduction in the inflammatory response to PAO-1 
infection. Taken together these data suggest that PAO-1 infection is responsible for the activation of 
the SL catabolic pathway. 
Based on this evidence, I investigated the effect of PAO-1 infection on the enzymatic activity of 
SMase and of the main glycohydrolases involved in the regulation of ceramide content as GBA1, 
GBA2, β-galactosidase and β-hexosaminidase, in CuFi-1 and NuLi-1 cells. 
First, I infected the CuFi-1 and NuLi-1 cells with heat killed PAO-1 for 4h; after the infection, I 
measured the hydrolases activity associated with the total cell lysate.   
Interestingly, I observed a slight increase, only for the intracellular SMase activity of infected NuLi-
1 cells but I did not find any significant difference in the activity of the total cell hydrolases of CuFi-
1 and NuLi-1, between infected and not infected cells (figure 12 and figure 13). 
  
Figure 11 Effect of Pseudomonas aeruginosa infection on the sphingolipid composition of CuFi-1 and NuLi-1 cell line; GlcCer: 
glucosylceramide; SM: sphingomyelin.  
Semi quantitative graph of sphingolipids species of CuFi-1 and NuLi-1 cells, infected or not with PAO-1. The sphingolipids are represented 
as percentage of radioactivity. 
Cer: ceramide; GlcCer: glucosylceramide; SM: sphingomyelin  
PAO-1: Pseudomonas aeruginosa CTRL: Not infected cells 
 *p<0.05 vs CTRL 
 
42 Results 
 
 
 
 
 
 
 
 
 
 
Figure 12 Effect of Pseudomonas aeruginosa infection on the activity of total cell hydrolases of CuFi-1 cells.  
The measurement of the hydrolases activity was conducted on cell lysate using an in vitro assay and artificial fluorigenic substrates. Before 
the assay, the cells were treated for 4 hours with PAO-1. The same cells, not infected with PAO-1, were used as control.  
The enzymatic activity is expressed as pmoles of products, on mg of proteins, per hour. 
GBA1: β-Glucosidase 1; GBA2: β-Glucosidase 2; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase  
PAO-1: Pseudomonas aeruginosa; Ctrl: Not infected cells 
 
 
Figure 13 Effect of Pseudomonas aeruginosa infection on the activity of total cell hydrolases of NuLi-1 cells.  
The measurement of the hydrolases activity was conducted on cell lysate using an in vitro assay and artificial fluorigenic substrates. Before the assay, 
cell were treated for 4 hours with PAO-1. The same cells, not infected with PAO-1, were used as control  
The enzymatic activity is expressed as pmoles of products on mg of proteins per hour. 
GBA1: β-Glucosidase; GBA2: β-Glucosidase 2; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase  
PAO-1: Pseudomonas aeruginosa; Ctrl: Control 
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Subsequently, I measured the activity of GBA1, GBA2, β-Gal and β-Hex associated with the cell 
surface of CuFi-1 and NuLi-1 cells subjected or not to PAO-1 infections.  
Even in the hydrolases activity associated with the PM, I did not observe any significant difference 
between infected and not infected cells, for both CuFi-1 and NuLi-1 cell line for the exception of an 
increase in β-Gal activity in infected NuLi-1 cells (Figure 14 and 15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The high-throughput cell live enzymatic assay, used to measure the hydrolases activity associated to 
the plasma membrane, allows determining the enzymatic activity associated with the entire cell 
surface, without the possibility to focus on a particular plasma membrane area.  
It is known that sphingolipids within plasma membrane segregate and form specific membrane 
domain called lipid rafts that are involved in the activation and regulation of different intra-cellular 
pathways. 
In order to study the involvement of this particular membrane domain, I labeled cell SLs at the steady 
state with [1-3H]-sphingosine and then I infected both CuFi-1 and NuLi-1 cell lines with PAO-1 for 
4 hours. Finally, I isolated the lipid rafts from infected and not infected cells, as detergent resistant 
membrane (DRM) following the procedure described in details in “material and method”.  
Figure 14 Effect of Pseudomonas aeruginosa infection on PM 
hydrolases of CuFi-1 cells. The measurement of the plasma 
membrane hydrolases activity was conducted on living cells, 
using artificial fluorigenic substrates. Before the assay, cell 
were treated for 4 hours with PAO-1. The same cells, not 
infected with PAO-1, were used as control 
The enzymatic activity is expressed as pmoles of products on 106 
per hour. 
GBA1: β-Glucosidase 1; GBA2: β-Glucosidase 2; β-Gal:  
β-Galactosidase; β-Hex: β-Hexosaminidase  
PAO-1: Pseudomonas aeruginosa; Ctrl: not infected 
*p<0.05 vs CuFi-1 
  
Figure 15 Effect of Pseudomonas aeruginosa infection on 
PM hydrolases of NuLi-1 cells. The measurement of the 
plasma membrane hydrolases activity was conducted on 
living cells, using artificial fluorigenic substrates. Before 
the assay, cell were treated for 4 hours with PAO-1. The 
same cells, not infected with PAO-1, were used as control. 
The enzymatic activity is expressed as pmoles of products 
on 106 per hour. 
GBA1: β-Glucosidase 1; GBA2: β-Glucosidase 2; β-Gal:  
β-Galactosidase; β-Hex: β-Hexosaminidase 
PAO-1: Pseudomonas aeruginosa; Ctrl: not infected   
*p<0.05 vs NuLi-1 
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In order to isolate the DRM fraction, I loaded on a discontinuous sucrose gradient the same amount 
in term of volume and protein of cells, lysed with 1% Triton X-100. After ultra-centrifugation, I 
collected eleven fraction and I measured the radioactivity associated to each of them.  
As expected, I found an enrichment in the radioactivity in low-density fraction 4 and 5 suggesting a 
sphingolipid enrichment. The remaining radioactivity was associated with the high-density (HD) 
fraction. The HD fraction represents all the cell membrane part, solubilized through the action of the 
detergent Triton X-100.  
Interestingly in both CuFi-1 and NuLi-1 cells, PAO-1 infection causes a 20 % increase of the 
radioactivity associated with the DRM (figure 16).  
 
 
 
Furthermore, I analyzed the sphingolipid composition of DRM and HD of CuFi-1 and NuLi-1 cells, 
infected or not with PAO-1. Total lipid extract obtained from DRM and HD fraction were subjected 
to a two phase partitioning obtaining an organic and aqueous phase. 
Subsequently I analyzed the sphingolipid pattern associated to both organic and aqueous phase. 
Interestingly, I found an intriguing difference in the composition of DRM-associate ganglioside 
between CuFi-1 and NuLi-1 cell line. In particular, the main ganglioside of CuFi-1 cells is GM3, 
whereas in NuLi-1 cells is GM1.  
In the DRM fraction of CuFi-1 cells infected with PAO, I found an increase of ceramide, SM and 
GM1 content. Whereas, HD fractions of CuFi-1 infected cells are characterized by a reduced content 
of SM and GM3 and by an increase in ceramide level again (figure 17). 
 
Figure 16 Radioactive sphingolipids distribution 
Radioactive sphingolipid distribution among gradient fractions obtained from CuFi-1 and NuLi-1 cells infected or not with 
Pseudomonas aeruginosa (PAO-1).  
DRM: detergent resistant membrane fractions HD: high-density fractions CTRL: not infected cells.  
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On the other hand, the DRM of NuLi-1 cells infected with PAO-1 show a reduction of ganglioside 
GD1a, followed by an increase in SM, GM3 and GM1 content, compared to control cells. I did not 
observe a significant increase of ceramide in DRM of infected NuLi-1 cells compared to control. In 
HD fraction, I did not found any significant differences in the sphingolipid pattern between control 
and infected cells, except for a slight increase in GM3 content (figure 18). 
  
Figure 17 Sphingolipids pattern of DRM and HD fractions obtained from CuFi-1 cells, treated or not with Pseudomonas aeruginosa 
Up: Autoradiography of HTLC of radioactive lipids contained in the organic phase (left) and aqueous phase (right) obtained from 
detergent resistance membrane (DRM) and high-density (HD) fractions of CuFi-1 cells, infected or not with PAO-1.  
Each sample was loaded at parity of radioactivity.  
Down: Semi quantitative graph of sphingolipids species. The sphingolipids are represented as dpm associate with the DRM or HD fraction.  
Cer: ceramide; GlcCer: glucosylceramide; PE: phosphatidylethanolamine; SM: sphingomyelin. GM3, GM1, GD1a: ganglioside 
PAO-1: Pseudomonas aeruginosa; Ctrl: not infected cells 
*p<0.05 vs DRM/HD ctrl 
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In addition, I found that in CuFi-1 cells, the modification of sphingolipid DRM composition is also 
associated with changes in the protein composition of DRM present at cell surface level (figure 19). 
In fact, the protein pattern obtained by immunoprecipitation of the biotinylated proteins associated 
with the cell surface is different between infected and not infected cells.  
  
Figure 18 Sphingolipids pattern of DRM and HD fractions obtained from NuLi-1 cells, treated or not with Pseudomonas aeruginosa 
Up: Autoradiography of HTLC of radioactive lipids contained in the organic phase (left) and aqueous phase (right) obtained from 
detergent resistance membrane (DRM) and high-density (HD) fractions of NuLi-1 cells, infected or not with PAO-1.  
Each sample was loaded at parity of radioactivity.  
Down: Semi quantitative graph of sphingolipids species. The sphingolipids are represented as dpm associate with the DRM or HD 
fraction. 
Cer: ceramide; GlcCer: glucosylceramide; PE: phosphatidylethanolamine; SM: sphingomyelin; GM3, GM1, GD1a: ganglioside 
 PAO-1: Pseudomonas aeruginosa Ctrl: not infected cells 
*p<0.05 vs DRM/HD ctrl 
 
 
47 Results 
 
These data suggest that PAO1 infection causes a reorganization of the lipids rafts both in term of 
protein and lipid composition.  
Furthermore, I investigated the effect of PAO-1 infection on the hydrolases associated with the DRM 
fraction obtained from CuFi-1 and NuLi-1 cells. 
In CuFi-1 cells, I was able to measure the activity of GBA1, β-Gal, β-Hex and SMase. Unfortunately, 
I could not measure the activity of GBA2 that is inhibited by the presence of the Triton X-100.  
The obtained results show that I found a significant increase in all the DRM associated activities upon 
infection with PAO-1 (figure 20). In particular, the data I obtained demonstrate that GBA1 and SMase 
activities have doubled, and β-Gal and β-Hex increased more than three fold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 Effect of Pseudomonas aeruginosa infection on protein composition of the external leaflet of DRM of CuFi-1 cells  
Immunoblotting images of protein pattern obtained by immunoprecipitation of the biotinylated proteins associate with the cells surface 
of CuFi-1 cells infected or not with PAO-1. 
PAO-1: Pseudomonas aeruginosa; Ctrl: not infected cells 
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Figure 20 Hydrolases activity associate with DRM fractions from CuFi-1 cells, infected or not with PAO-1.  
The measurement of the hydrolases activity was conducted on DRM fraction, using an in vitro assay based on artificial fluorigenic 
substrates. The enzymatic activity was evaluated on the same volume of DRM fraction. 
The enzymatic activity is expressed as pmoles of products, on total volume of fraction, per hour.  
GBA1: β-Glucosidase 1; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase  
DRM: detergent resistance membrane fraction; PAO-1: Pseudomonas aeruginosa; Ctrl: not infected cells 
*p<0.05 vs DRM Ctrl 
 
48 Results 
I measured the same hydrolases activity in HD fraction, but as shows by the graphs in figure 21, I did 
not find any significant difference in term of enzymatic activity between infected and not infected 
cells. I performed the same analyses on DRM and HD fractions of NuLi-1 cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 21 Hydrolases activity associate with HD fractions from CuFi-1 cells infected or not with PAO-1.  
The measurement of the hydrolases activity was conducted on HD fraction, using an in vitro assay based on artificial fluorigenic 
substrates. The enzymatic activity was evaluated on the same volume of HD fraction 
The enzymatic activity is expressed as pmoles of products on volume of fraction per hour.  
GBA1: β-Glucosidase1 β-Gal: β-Galactosidase β-Hex: β-Hexosaminidase SMase: Sphingomyelinase  
HD: high density fraction PAO-1: Pseudomonas aeruginosa Ctrl: not infected cells 
*p<0.05 vs DRM Ctrl 
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49 Results 
Interestingly, the data I obtained demonstrate a decrease of all DRM associated activities in DRM 
derived from cells subjected to PAO-1 infection (figure 22), an opposite effect in respect to CuFi-1 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As CuFi-1 cells, even in this case, I did not find any significant differences in the hydrolases activity 
associated with HD fraction, between infected and not infected cells (figure 23). 
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Figure 22 Hydrolases activity associate with DRM fraction from NuLI-1 cells, infected or not with PAO-1.  
The measurement of the hydrolases activity was conducted on DRM fraction, using an in vitro assay based on artificial 
fluorigenic substrates. The enzymatic activity was evaluated on the same volume of DRM fraction. 
The enzymatic activity is expressed as pmoles of products on volume of fraction per hour.  
GBA1: β-Glucosidase 1; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase 
 DRM: detergent resistant membrane fraction; PAO-1: Pseudomonas aeruginosa; Ctrl: Control 
*p<0.05 vs DRM Ctrl 
 
50 Results 
 
 
These data clearly show that PAO-1 infection causes important changes in the DRM structure. 
The information obtained from CuFi-1 cells suggest that PAO-1 infection leads to the activation of 
SL catabolic pathway, which culminates in the production of ceramide, followed by changes also in 
the protein composition.   
Concerning NuLi-1 cells, the behavior of the hydrolases observed after PAO-1 infection is quiet 
difficult to understand. For sure, the glycohydrolases involved in glycosphingolipids catabolism have 
a role in the creation of a good arrangement of cell surface, suitable to manage the bacterial infection.  
However, we are not able to explain in detail, the meaning of this molecular mechanism.  
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Figure 23 Hydrolases activity associate with HD fraction from NuLi-1 cells, infected or not with PAO-1. 
The measurement of the hydrolases activity was conducted on HD fraction, using an in vitro assay based on artificial 
fluorigenic substrates. The enzymatic activity was evaluated on the same volume of HD fraction. 
The enzymatic activity is expressed as pmoles of products on volume of fraction per hour.  
GBA1: β-Glucosidase 1; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase  
HD: high-density fraction; PAO-1: Pseudomonas aeruginosa; CTRL: not infected cells 
 
 
 
 
 
51 Results 
PAO1 infection alter the signaling pathway mediated by CD95  
 
To figure out the possible molecular mechanism linking the cell surface modification after bacterial 
infection, with the activation of inflammatory response, and in particular, the release of IL-8, I 
investigated the possible activation of CD95 pathway, including the regulatory protein phospho-
FADD, RIP, NF-kB and Caspase 8. 
Clustering of activated receptors in ceramide-enriched membrane domains was demonstrated in 
literature for several receptors including CD95, DR5, or CD40 [Schutze, Tchiko, et al 2008]. 
To investigate this pathway, I infected the CuFi-1 cells with PAO-1 for 4 h, and then I conducted a 
western blot analysis on the obtained lysates. 
 
 
 
The obtained data suggest the probable involvement of this pathway as possible link between the 
modification occurring at the cell surface after PAO-1 infection and the release of IL-8. In fact, as 
reported in figure 24, I found that all the principal regulatory protein of the pro-inflammatory pathway 
are activated, including the mediator phospo-FADD. In addition, the presence of RIP suggests that 
the extrinsic apoptotic pathway is not activated, further confirmed by the absence of Caspase-8. 
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Figure 24 Effect of Pseudomonas aeruginosa (PAO-1) infection on the activation of CD95 pathway in CuFi-1 cells 
Left: Immunoblotting analyses, obtained from CuFi-1 cells infected or not with PAO-1.  
Right: quantitative analyses of protein, expressed in arbitrary units compared to GAPDH. 
PAO-1: Pseudomonas aeruginosa; CTRL: not infected cells   
*p<0.05 vs CTRL 
 
 
52 Results 
CF and non-CF epithelial bronchial cells stable-overexpressing GBA2 
 
Characterization of CuFi-1 and NuLi-1 cell overexpressing GBA2 
 
Evidence in literature [Loberto, Tebon, et al. 2014] on the correlation between GBA2 silencing and 
the reduction of the IL-8 mRNA expression in CuFi-1 cells, both infected or not with P.aeruginosa, 
suggests that GBA2 could have an important role in the activation of the inflammatory response in 
CF. However, the details of molecular mechanism involving GBA2 are still unknown.  
Some technical limits make difficult to study GBA2. In fact, as reported above, the use of detergent 
Triton X-100 for the DRM isolation inhibits the GBA2 activity. In addition, an efficient antibody 
against GBA2 is not commercially available. 
In order to overtake these limits, I decided to stably-overexpress GBA2 linked with GFP in both 
NuLi-1 and CuFi-1 cells. 
As control cells, I generated a Mock cells line by the overexpression of the only GFP. After three 
weeks, several clones were selected and I morphologically analyzed it by confocal microscopy, to 
detect the GFP-tagged GBA2 (figure 25). 
 
 
 
 
 
 
 
 
 
 
  
Figure 25 Confocal images of CuFi-1 and NuLi-1 overexpressing GFP (Mock), CuFi-1 and NuLi-1 overexpressing GBA2-tagged 
GFP (GBA2-GFP) 
 
53 Results 
As shown in figure 25 I was able to obtain clones stably overexpressing GBA2 at the PM level for 
both cell lines. 
 I started to measure the activity of GBA2 in CuFi-1 mock (GFP) and in GBA2 overexpressing cells 
(GBA2-GFP) either intracellularly or directly at the cell plasma membrane.  
 
As shown in figure 26 CuFi-1 GBA2-GFP cells are characterized by 80-fold increase in the total 
GBA2 activity and by an increase of 40 fold increase at the cell surface.  
Several evidences in literature reports that the cells react to the alteration of the activity of one of the 
enzymes involved in the SL metabolism by modifications in the activity of other enzymes involved 
in the same catabolic pathway [Aureli, Bassi, et al. 2012]. For this reason I measured in mock and 
CuFi-1 GBA2-GFP the activity of the main cell hydrolases. 
 
  
Figure 26 Total and plasma membrane enzymatic activity of GBA2 measured in CuFi-1 overexpressing GFP and in CuFi-1 
overexpressing GBA2 tagged-GFP.  
The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro assay based on artificial fluorigenic 
substrates.  
The enzymatic activity is expressed as pmoles of products on mg of proteins per hour.  
The measurement of the plasma membrane enzymatic activity of GBA2 was conducted on living cells, using artificial fluorigenic 
substrates. The enzymatic activity is expressed as pmoles of products on 106 cells per hour. 
GBA2: β-Glucosidase 2;  
CuFi-1 Mock: CuFi-1 overexpressing GFP; CuFi-1 GBA2-GFP A/ B: CuFi-1 overexpressing GBA2 tagged with GFP 
*p<0.05 vs Mock   
 
54 Results 
 
 
The results obtained show that the overexpression of GBA2 in CuFi-1 cells causes a reduction of β-
Hex of more than double and a reduction of SMase activity from ~180000 pmoles/mg/h to less than 
100000 pmole/mg/h in the total cell lysate (figure 27). Furthermore, I evaluated in both mock and 
GBA2 overexpressing CuFi-1 cells the activity of the β-glucocerebrosidase GBA1, β-galactosidase 
and β-hexosaminidase directly at the plasma membrane of living cells. As shown in figure 28 I found 
an important increase of β-gal compared to mock cells. 
In addition, GBA1 is more than doubled, especially in the second clone (CuFi-1 GBA2-GFP B), 
whereas β-Hex remains constant.  
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Figure 27 Total cell associated hydrolases activity of CuFi-1 overexpressing GFP and overexpressing GBA2-tagged GFP.  
The measurement of the hydrolases activity was conducted on cell lysate using an in vitro assay based on artificial fluorigenic 
substrates. The enzymatic activity is expressed as pmoles of products, on mg of proteins, per hour. 
GBA1: β-Glucosidase1; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase GBA2:   
CuFi-1 Mock: CuFi-1 overexpressing GFP; CuFi-1 GBA2-GFP A/ B: CuFi-1 overexpressing GBA2 tagged with GFP 
 *p<0.05 vs Mock 
 
 
 
55 Results 
Figure 28 Plasma membrane hydrolases activity in CuFi-1 overexpressing GFP and CuFi-1 overexpressing GBA2-tagged GFP. 
The measurement of the plasma membrane hydrolases activity was conducted on living cells, using artificial fluorigenic substrates.  
The enzymatic activity is expressed as pmoles of products, on 106 cells, per hour.  
.GBA1: β-Glucosidase; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase  
CuFi-1 Mock: CuFi-1 overexpressing GFP; CuFi-1 GBA2-GFP A/ B: CuFi-1 overexpressing GBA2 tagged with GFP 
*p<0.05 vs Mock 
 
 
 
*p<0.05vs Mock 
 
 
 
 
I characterized also the NuLi-1 cells overexpressing GBA2-GFP. As show in figure 29 
overexpressing cells show 100-fold increase in GBA2 activity in total cell lysate in comparison to  
Mock cells. Whereas, at the cell surface the overexpression causes an increase of GBA2 activity of 
about 30-fold. 
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Figure 29 Total and plasma membrane enzymatic activity of GBA2 measured in NuLi-1 overexpressing GFP and in NuLi-1 overexpressing 
GBA2-tagged GFP.  
The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro assay and artificial fluorigenic substrates.  
The enzymatic activity is expressed as pmoles of products on mg of proteins per hour.  
The measurement of the plasma membrane enzymatic activity of GBA2 was conducted on living cells, using artificial fluorigenic substrates. 
The enzymatic activity is expressed as pmoles of products on 106 cells per hour. 
 GBA2: β-Glucosidase 2; NuLi-1 Mock: NuLi-1 overexpressing GFP; NuLi-1 GBA2-GFP A/ B: NuLi-1 overexpressing GBA2 tagged with GFP 
*p<0.05 vs Mock  
 
56 Results 
Even in this case I measured the activity of the GBA2- correlated hydrolases both intracellularly and 
at the plasma membrane. As shown in figure 30 I found no changes in the intracellular activity of β-
glucocerebrosidase GBA1, β-galactosidase and β-hexosaminidase between mock and overexpressing 
GBA2 NuLi-1 cells for the exception of slight decrease of GBA1 and SMase activity in one of the 
generated monoclonal cell line.  
 
 
 
Concerning the activities associated with plasma membrane, I found a slight increase in β-
glucocerebrosidase and β-galactosidase whereas β- hexosaminidase activity is reduced (figure 31). 
I analyzed the effect of GBA2 overexpression on the SLs pattern of both CuFi-1 and NuLi-1 cells 
overexpressing GBA2 by a metabolic labeling at the steady state using the radioactive precursor [1-
3H]-sphingosine. 
As expected, I found that both CuFi-1 and NuLi-1 cells overexpressing GBA2, are characterized by 
a decrease of GlcCer, associated to an increase of Cer and SM (figure 32). 
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Figure 30 Total cell associated hydrolases activity in NuLi-1 overexpressing GFP (Mock) and NuLi-1 overexpressing GBA2-
tagged GFP.  
The measurement of the hydrolases activity was conducted on cell lysate using an in vitro assay based on artificial fluorigenic 
substrates. The enzymatic activity is expressed as pmoles of products, on mg of proteins, per hour. 
GBA1: β-Glucosidase1; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase; SMase: Sphingomyelinase  
NuLi-1 Mock: NuLi-1 overexpressing GFP; NuLi-1 GBA2-GFP A/ B: NuLi-1 overexpressing GBA2 tagged with GFP 
*p<0.05 vs Mock 
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Figure 31 Plasma membrane hydrolases activity in NuLi-1 overexpressing GFP and CuFi-1 overexpressing GBA2-tagged GFP.  
The measurement of the plasma membrane hydrolases activity was conducted on living cells, using artificial fluorigenic substrates.  
The enzymatic activity is expressed as pmoles of products on 106 cells per hour. NuLi-1 GBA2 GFP: NuLi-1 cell overexpressing GBA2 
tagged with GFP.  
GBA1: β-Glucosidase; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase  
NuLi-1 Mock: NuLi-1 overexpressing GFP; NuLi-1 GBA2-GFP A/ B: NuLi-1 overexpressing GBA2 tagged with GFP 
 *p<0.05 vs Mock 
 
*p<0.05vs Mock 
 
58 Results 
 
 
 
Interestingly, these data suggest that part of the ceramide produced by action of GBA2, is probably 
converted to SM as suggested by Sorli and colleagues [Sorli S.C et al. 2013]. This process could 
explain the high level of SM observed in the overexpressing cells.  
  
Figure 32 Radioactive sphingolipids composition of CuFi-1 and NuLi-1 cell line overexpressing GBA2 compared to mock cells  
Up: Autoradiography of HTLC of radioactive lipids contained in the organic phase obtained from CuFi-1 (left) and NuLi-1 (right) 
overexpressing GBA2 or overexpressing GFP. Each sample was loaded at parity of radioactivity.  
Down: Semi quantitative graph of sphingolipids species. The sphingolipids are represented as percentage of radioactivity.  
Cer: ceramide; GlcCer: glucosylceramide; PE: phosphatidylethanolamine; SM: sphingomyelin  
Mock: overexpressing GFP; GBA2-GFP A/ B: overexpressing GBA2 
*p<0.05 vs CuFi-1/NuLi-1 Mock cells 
 
59 Results 
Pro-inflammatory state of CuFi-1 cells overexpressing GBA2 
 
Since it has been demonstrated that the silencing of GBA2 cause a strong reduction of IL-8 in the 
pro-inflammatory state of CF, I wondered which effect could have the overexpression of GBA2 on 
the basal inflammatory state compared to CuFi-1 cells. 
To address this issue, I measured the IL-8 mRNA expression in GBA2 overexpressing CuFi-1 cells 
and I compared the obtained result to CuFi-1 cells.  
As shown in figure 33, GBA2 overexpressing cells are characterized by a significant increase of IL-
8 mRNA, and this data further support the role of GBA2 in the pro-inflammatory state of CF lung 
disease 
 
 
Since I did not observe any significant differences between NuLi-1 cells and NuLi-1 overexpressing 
GBA2, in the basal IL-8 mRNA expression, I focused my attention manly on CuFi-1 cells.  
 
Behavior of lipid raft in CuFi-1 cell overexpressing GBA2  
 
GBA2 overexpression in CuFi-1 cells is responsible for changes in the plasma membrane composition 
of both sphingolipids and enzymes involved in their catabolism, which correlates with an increased 
basal production of pro-inflammatory IL-8.  
I decided to investigate if the potential perturbation of plasma membrane caused by the 
overexpression of GBA2 was able to lead to a different behavior of lipid rafts in these cells. 
  
Figure 33 Pro-inflammatory state of CuFi-1 cells overexpressing GBA2 compared with CuFi-1 cells  
mRNA expression of IL-8 of CuFi-1 cells compared with CuFi-1 cells *p<0.05 vs CuFi-1 cells 
 
 
 
 
 
60 Results 
Interestingly, figure 34 show that GBA2 overexpressing cells are characterized by an increased 
radioactivity associated to the DRM, compared to CuFi-1 cells.  
Subsequently I compared the sphingolipid composition of DRM of CuFi-1 to DRM of CuFi-1 GBA2 
overexpressing cells.  
 
 
 
 
 
As shown in figure 35, I found that GBA2 overexpression causes a strong increase of Cer content in 
the DRM without affecting the SM level.  
Subsequently, I measured the enzymatic activity of GBA1, β-galactosidase and β-hexosaminidase, 
associated with the DRM of CuFi-1 cells overexpressing GBA2 and I compared it with the hydrolases 
of DRM of CuFi-1 cells.  
Figure 34 Radioactive sphingolipid distribution.  
Radioactive sphingolipid distribution among gradient fractions obtained from CuFi-1 overexpressing GBA2 compared with radioactive 
sphingolipid distribution among gradient fractions obtained from CuFi-1 cells. 
DRM: detergent resistant membrane fractions; HD: high-density fractions; CuFi-1 GBA2- GFP: CuFi-1 overexpressing GBA2 tagged with 
GFP 
  
 
 
Figure 35 Comparison between lipids obtained from detergent resistance membrane of CuFi-1 and CuFi-1 cells overexpressing 
GBA2. 
Semi quantitative graph of sphingolipids species. The sphingolipids are represented as dpm associate with the DRM fraction. 
Cer: ceramide; SM: sphingomyelin.  
CuFi-1 GBA2-GFP: CuFi-1 overexpressing GBA2 tagged with GFP; DRM: detergent resistant membrane 
*p<0.05 vs CuFi-1 
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Interestingly, the graphs of enzymatic activities show that GBA2 overexpression leads to a strong 
increase of activity of the all hydrolases, at the level of DRM fraction (figure 36).  
These data further support the role of GBA2 in the regulation of the pro-inflammatory state of CuFi-
1 cells.  
 
 
 
 
 
 
 
 
 
  
Figure 36 Hydrolases activity associate with DRM fraction from CuFi-1 cells overexpressing GBA2 compared with CuFi-1 cells 
The measurement of the hydrolases activity was conducted on DRM fraction, using an in vitro assay based onartificial fluorigenic 
substrates. The enzymatic activity was evaluated on the same volume of DRM fraction 
The enzymatic activity is expressed as pmoles of products, on volume of fraction, per hour.  
GBA1: β-Glucosidase 1; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase 
DRM: detergent resistance membrane fraction; CuFi-1 GBA2: Cufi-1 overexpressing GBA2 
*p<0.05 vs CuFi-1 
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Behavior of lipid raft in GBA2 overexpressing CuFi-1 cells subjected to PAO-1 infection 
 
Given that the interesting results obtained by the analyses of DRM obtained from GBA2 
overexpressing Cells, I decided to investigate the effect of PAO-1 infection in this kind of cells.  
I infected the cells with PAO-1 for 4 hour, as control I used the same cell not infected and then, I 
proceeded with the isolation of the DRM.  
 
 
As done with the DRM isolation of CuFi-1 and NuLi-1 cells, I collected eleven fractions and I 
measured the radioactivity associated with each of them. 
As expected, I found an enrichment in the radioactivity in low-density fraction 4 and 5 that correspond 
to DRM fraction (figure 37). The remaining radioactivity was associated to the high-density (HD) 
fraction.  
Interestingly in these GBA2 overexpressing cells, PAO-1 infection causes only a small increase in 
the radioactivity associated with the DRM (figure 37).  
Subsequently I analyzed the sphingolipid composition of DRM and HD of GBA2 overexpressing 
CuFi-1 cells, infected or not with PAO-1 (figure 38). 
Unexpectedly, I found that PAO-1 infection causes a decrease of SM and Cer in the DRM, if 
compared to the uninfected cells.  
  
Figure 37 Radioactive sphingolipid distribution  
Radioactive sphingolipid distribution among gradient fractions obtained from CuFi-1 overexpressing GBA2 infected or not with Pseudomonas 
aeruginosa 
DRM: detergent resistant membrane fractions; HD: high-density fractions; CTRL: not infected cells PAO-1: Pseudomonas aeruginosa 
 
 
 
among gradient fractions obtained from CuFi-1 cells overexpressing GBA2 subjected or not to Pseudomonas aeruginosa (PAO-1) infection 
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Whereas, in HD of infected cells I found a slight increase of Ceramide with respect to not infected 
cells, and I did not find any significant difference in the level of SM between control and infected 
cells. Subsequently, I measured the enzymatic activity of GBA1, β-Galactosidase and β-
Hexosaminidase. 
Interestingly, the graphs of enzymatic activity (figure 39) show that PAO-1 infection, in these cells, 
leads to a strong decrease of activity of some hydrolases such as β-Gal and β-Hex in the DRM 
fraction. In HD fraction, I did not find any significant difference between control and infected cells 
in all the enzymatic activities analyzed (figure 40). 
These data suggest that probably this kind of cells does not need to response to PAO-1 infection with 
a recruitment of all the hydrolases at the level of DRM. In fact, they have already a great amount of 
GBA2 able to produce Ceramide as a response to bacterial infection.  
This speculation further support the role of GBA2 in the inflammatory response to P. aeruginosa 
infection in CF epithelial bronchial cell.  
Figure 38 Lipid pattern of high-density fraction of CuFi-1 cells overexpressing GBA2, infected or not with Pseudomonas 
aeruginosa. 
Up:  Autoradiography of HTLC of radioactive lipids contained in the organic phase obtained from CuFi-1 overexpressing GBA2 
treated or not with Pseudomonas aeruginosa. Each sample was loaded at parity of radioactivity.  
Down: Semi quantitative graph of sphingolipids species. The sphingolipids are represented as dpm associate with the DRM (left) and 
HD (right) fraction.  
Cer: ceramide; SM: sphingomyelin  
 PAO-1: Pseudomonas aeruginosa Ctrl: Not infected cells; DRM: detergent resistant membrane fraction; HD: high-density fraction 
CuFi-1 GBA2-GFP; CuFi-1 overexpressing GBA2 
*p<0.05 vs Ctrl 
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Figure 39 Hydrolases activity associate with detergent resistant membrane fraction from CuFi-1 cells overexpressing GBA2, 
infected or not with Pseudomonas aeruginosa.  
The measurement of the hydrolases activity was conducted on DRM fraction, using an in vitro assay and artificial fluorigenic 
substrates, To normalize the data I did not consider the same amount of protein per sample, for each tested hydrolases, but I consider 
the same volume of DRM fraction. The enzymatic activity are expressed as pmoles of products on volume of fraction per hour.  
Β Glc Tot: Total β-Glucosidase; GBA2 β-Glucosidase 2; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase 
DRM: detergent resistance membrane fraction; PAO-1: Pseudomonas aeruginosa; CTRL: Control 
*p<0.05 vs CTRL 
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Figure 40 Hydrolases activity associate with high-density fraction from CuFi-1 cells overexpressing GBA2 infected of nor with 
PAO-1.  
The measurement of the hydrolases activity was conducted on HD  fraction, using an in vitro assay and artificial fluorigenic substrates, 
To normalize the data I did not consider the same amount of protein per sample, for each tested hydrolases, but I consider the same 
volume of HD fraction. The enzymatic activity are expressed as pmoles of products on volume of fraction per hour.  
Β Glc Tot: Total β-Glucosidase; GBA2 β-Glucosidase 2; β-Gal: β-Galactosidase; β-Hex: β-Hexosaminidase 
HD: High-density fraction; PAO-1: Pseudomonas aeruginosa; CTRL: Control 
*p<0.05 vs CTRL 
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Development of a nanoparticle-based siRNA-GBA2 delivering system 
 
Identification of the best siRNA sequences to down-regulate GBA2 and to obtain the highest 
anti-inflammatory effect 
 
This PhD project is based on some preliminary results, reported by Loberto and colleagues [Loberto, 
Tebon, et al. 2014], demonstrating that the GBA2 silencing results in a reduction of IL-8 mRNA level 
in CF bronchial cells. The anti-inflammatory effect was observed not only after the infection with 
P.aeruginosa but also in absence of bacterium. This evidence suggests the possibility to use specific 
siRNA sequences to down-regulate GBA2, as a new therapeutic option to reduce the intrinsic pro-
inflammatory state of CF tissue and the inflammatory response to P. aeruginosa infection. 
To this aim, I tested six difference siRNA sequences, which target different part of GBA2 mRNA 
sequence (figure 41). 
 
 
I tested the silencing efficiency of these six different sequences in CuFi-1 cells, and then I tested the 
silencing efficiency of the all-possible combination of each.  
As first read out system, I measured the GBA2 activity in cell transfected with single siRNA or with 
a combination of them using Lipofectamine 20000 as transfectant reagent.  
Figure 41 Six different siRNA sequences, targeting different part of human GBA2 mRNA sequence 
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As results, I found that the combination of the two siRNAs, targeting the catalytic site of the 
enzyme (Hs_GBA2_1 and Hs_GBA2_5) was the best to silence GBA2; in fact, the GBA2 activity 
was more than 70% decreased (figure 42). 
 
 
I confirmed the efficacy of this combination, through the measurement of the expression level of 
GBA2 mRNA (figure 43). 
 
After the identification of the best combination of siRNAs, I studied the effect of GBA2 silencing on 
the inflammatory response to bacterial infection.  
To this purpose, I administered the combination of the two siRNA to CuFi-1 cells, and then, I infected 
the cells with Pseudomonas aeruginosa. As control, I used the same silenced cells not infected.   
Figure 42 Effect of the GBA2-siRNA alone or in different combination, on the GBA2 activity in CuFi-1 cells. 
The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro assay and artificial fluorigenic 
substrates. The enzymatic activity are expressed as pmoles of products on mg of proteins per hour. The colors code is referred to the 
legend reported in the figure 35 
*p<0.003 vs scramble, ** p< 0.005 vs other group 
Figure 43 Effect of the combination of Hs_GBA2_1 and Hs GBA2_5 on the GBA2 mRNA expression in CuFi-1 cells.  
* p<0.001 vs scrambled 
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I determined the IL-8 chemokine expression, trough qRT-PCR. As shows in figure 44, I found a 
significant low level of IL-8 in GBA2 transfected cells and I observed a further decrease after bacterial 
infection.  
 
These results suggest the possibility to control the inflammatory response in CF through the specific 
targeting of GBA2.  
 
Nanoparticles development for si-RNA-GBA2 delivering 
 
Since siRNA are very unstable oligonucleotides, especially in the cytosolic and extracellular 
environment, I tried to stabilize the nucleic acid by its condensation with protamine. For this reason, 
I started to investigate the effect of the protamine-siRNA condensation on the silencing capability of 
siRNA. 
As shown in figure 45, protamine alone does not exert any effect on GBA2 activity; moreover, the 
same efficiency in GBA2 silencing was obtained when the two selected siRNAs (1 and 5) were 
administered complexed with protamine. 
These results indicate that these experimental conditions fully assure siRNA integrity and availability. 
  
Figure 44 Effect of GBA2-siRNA 1 and 5 combined treatment in the intrinsic pro-inflammatory state and in inflammatory 
response to Pseudomonas aeruginosa in CuFi-1 cells.  
*p<0.0001 vs scramble 
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As reported above, I used Lipofectamine2000 as vector to administrate siRNA. Since Lipofectamine 
is a commercial mixture of cationic lipids, used only for research purpose, I decided in collaboration 
with a group of physicist, to change the vector adapting a lipoplex. Lipoplex is normally used for the 
systemic delivery of plasmids, but we tried to use it to deliver siRNA.  
The delivery of genetic material is an important field in development. Lipids and DNA/RNA 
spontaneously aggregate in solution and form structures similar to those of the bare lipids, being 
DNA/RNA embedded in their aqueous moieties. For in vitro transfection models, the delivery 
efficiency has been correlated to both the lipid composition and the structural features of the 
lipid/nucleic acid complexes.  
Among lipid-based nanovectors, an interesting class of core-shell nanoparticles has been shown to 
promote transfection efficiency in different experiments. They are obtained by precondensing the 
DNA with a fusogenic protein, namely protamine, before lipid interaction. 
We applied a selected class of cationic lipid based nanovectors for the delivery of siRNA against 
GBA2 in vitro. The selected lipid composition consists of a DC-Chol/DOPE mixture that have been 
already studied for the systemic delivery of plasmid DNA and siRNA. We prepared DC-Chol/DOPE-
siRNA lipoplexes (CL) and DC-Chol/DOPE-protamine/siRNA nanoparticles (NP). CL and NP allow 
studying the effectiveness of siRNA protection by protamine pre-condensation in relation to the 
delivery and the transfection efficiency in vitro. 
  
Figure 45 Influences of Protamine on the silencing efficiency of GBA2-siRNA 1 and 5 
The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro assay and artificial 
fluorigenic substrates. The enzymatic activity is expressed as pmoles of products, on mg of proteins, per hour.  
Protamine does not influence the silencing properties of GBA2-siRNA 1 and 5.  
*p> 0.005 vs scrambles 
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First, we performed the biophysical characterization of these nanoparticles. CL size distribution 
obtained by Dynamic Light Scattering (DLS) shows a well-defined population with low 
polydispersity and average hydrodynamic diameter DH = 206 nm (figure 46). Particles are positively 
charged with a Z-potential of 24±2 mV.  
After the biophysical characterization, I proceeded with the evaluation of the transfection power. I 
performed a set of preliminary experiments involved in the functional characterization of these two 
different “siRNA delivery system” in comparison with lipofectamine.  
In the first part of the experiments, I used a siRNA, linked with a green fluorophore, and I performed 
time course experiments of 5, 24 and 48 hours. Our aims were to study the cell delivery of the siRNA, 
the localization within the cells and the time stability in CuFi-1 cells line.  
As shown in figure 47, both lipoplexes and nanoparticles are able to enter into the cells faster with 
respect to the lipofectamine, as suggested by the increased fluorescence after 5 hours from the 
administration.  
In addition, during the time course, the cell organization seems to be different and, for the NP at 48 
hours, is possible to observe that part of fluorescence signal is within the nucleus. 
In term of quantity, the fluorescence associated with lipoplexes (CL) and NP are higher in comparison 
to lipofectamine, for all the time points tested.  
  
Figure 46 Characterization of lipid based nanoparticle with Dynamic light scattering  
Particle size distribution of a) CL lipoplexes and b) NP nanoparticles obtained by DLS at 25°C applying CONTIN analysis 
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Figure 47 Images of CuFi-1 cells treated with different lipid based nanoparticle and fluorescent siRNA 
Representative images, obtained with phase contrast microscopy and fluorescence microscopy, of cellular behavior of fluorescent 
siRNA delivered in CuFi-1 cells using lipoplexes (CL),  nanoparticles (NP) and commercial lipofectamine 2000 (LF) as control.  
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Subsequently, I performed a time course experiments to measure the GBA2 activity after 24h (figure 
48), 48h (figure 49) and 6 days (figure 50) from the transfection in order to evaluate the capability of 
different delivery systems to silence GBA2 and their influence on the stability of siRNA into the cells.  
 
Figure 48 Evaluation of GBA2, GBA1 and β-gal activity after 24 h from transfection  
Left: GBA2 activity in CuFi-1, treated with siRNA-GBA2 and siRNA scrambled loaded on lipofectamine, lipoplexes and nanoparticle 
after 24 h from transfection. The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro assay 
based on artificial substrates. 
Right: GBA1 and β galactosidase activity measured on the same cells. The enzymatic activity of cells, treated with siRNA, was expressed 
as percentage with respect to activity obtained from cells trated with scrambled. 
LF 2000: Lipofectamine 2000; CL: Lipoplexes; NP: nanoparticles; siRNA: siRNA against GBA2; Scr: Scrambled 
 
 
Figure 49 Evaluation of GBA2, GBA1 and β-gal activity after 48 h from transfection 
Left: GBA2 activity in CuFi-1, treated with siRNA-GBA2 and siRNA scrambled loaded on lipofectamine, lipoplexes and nanoparticle 
after 48 h from transfection. The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro assay 
based on artificial substrates. 
Right: GBA1 and β galactosidase activity measured on the same cells. The enzymatic activity of cells, treated with siRNA, was expressed 
as percentage with respect to activity obtained from cells trated with scrambled. 
LF 2000: Lipofectamine 2000; CL: Lipoplexes; NP: nanoparticles; siRNA: siRNA against GBA2; Scr: Scrambled 
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Figura 50 Evaluation of GBA2, GBA1 and β-gal activity after 6 days from transfection 
Left: GBA2 activity in CuFi-1, treated with siRNA-GBA2 and siRNA scrambled loaded on lipofectamine, lipoplexes and nanoparticle 
after 6 days from transfection. The measurement of the total GBA2 enzymatic activity was conducted on cell lysate using an in vitro 
assay based on artificial substrates. 
Right: GBA1 and β galactosidase activity measured on the same cells. The enzymatic activity of cells, treated with siRNA, was expressed 
as percentage with respect to activity obtained from cells trated with scrambled. 
LF 2000: Lipofectamine 2000; CL: Lipoplexes; NP: nanoparticles; siRNA: siRNA against GBA2; Scr: Scrambled 
 
At 24 h and 48 h, in CuFi-1 treated with the delivery system lipoplexes I observed a reduction of 20/ 
30% in the GBA2 activity. Concerning the nanoparticle system, I observed a reduction of 40/50%. 
After 6 days, all the delivery system tested cause a strong reduction in GBA2 activity. 
In order to control any possible off-target effect I measured also the enzymatic activity of GBA1 and 
β-Gal for all the time points. The results demonstrate that β-Gal are maintained constant during all 
the time course, we observed only a slight decrease of the activity of GBA1 after 6 days in cells 
treated with NP. 
After these experiments, I evaluated the toxicity of the different delivery system tested, analyzing the 
expression of cell damage biochemical markers such as LC3II and p62 for autophagy and caspase 3 
for apoptosis. I found that at 48 h, cells treated with CL are characterized by the activation of 
macroautophagy as indicated by the high level of LC3II and p62 (figure 51). 
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Figure 51 Immunoblotting analyses of CuFi-1 cells treated with siRNA anti-GBA2 loaded with lipofectamine, lipoplexes and 
nanoparticle. 
Immunoblotting analyses of the biochemical markers of cell damage: LC3II and p62 for autophagy and caspase 3 for apoptosis performed 
on CuFi-1 cells subjected to the treatment with siRNA-GBA2 loaded on lipofectamine, lipoplexes or nanoparticles  
LF: lipofectamine, CL: lipoplexes; NP: nanoparticles 
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Discussion  
 
Several studies in different CF models strongly support the relationship among sphingolipids, 
inflammation response and susceptibility to bacterial infection. A peculiar role seems to be played by 
ceramide; in fact, it has been demonstrated an increase in PM ceramide levels in CF bronchi that 
seems to be correlated with the pro-inflammatory status typical of CF lung disease [Brodlie, McKean, 
et al, Teichgraber, Ulrich, et al. 2008]. Several criticism emerge from the literature regarding the 
origin of the ceramide accumulated in CF bronchi.  
In fact, as well known, several metabolic pathways contribute to the ceramide production. Beside the 
main catabolic pathway occurring in lysosomes, the de novo biosynthesis and the hydrolysis of the 
sphingolipids triggered directly at the plasma membrane, by the action of the PM associated-
hydrolases, could play an important role [Aureli, Loberto, et al. 2011].  
Interestingly, it has been demonstrated in bronchial epithelial cells that part of ceramide is produced 
in response to Pseudomonas aeruginosa infection through the SM catabolism at the plasma 
membrane driven by the acid-sphingomyelinases [Grassme, Jendrossek, et al. 2003]. On the other 
hand, of particular relevance, bioactive ceramide could be produced by the action of PM-
glycohydrolases through GSL degradation at the cell surface, as demonstrated in human fibroblast 
[Sonnino and Prinetti, et al. 2010] and in cancer cells [Gobbi, Re, et al. 2010]. Nevertheless, limited 
information are available on the involvement of these enzymes in the Cystic Fibrosis lung disease.  
Recent data demonstrated that the pharmacological inhibition of GBA2, a key enzyme in the 
production of ceramide at the cell surface, as well as the down regulation of GBA2 expression, is 
associated with a significant reduction of the inflammatory response to P. aeruginosa infection. 
Moreover, the knocking-down of GBA2 is reported to cause a reduction of the intrinsic pro-
inflammatory state of CF epithelial bronchial cells [Loberto, Tebon, et al. 2014].  
Considering all these aspects, the specific aims of my PhD project were, i) the Identification of the 
molecular mechanism linking the PM glycohydrolases with the inflammation response in CF lung 
disease and ii) the development of a nanoparticles-based siRNA-GBA2 delivering system. 
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Involvement of PM hydrolases in the inflammation response in CF lung disease 
 
Based on the previous data published in the literature I investigated the role of the PM-
glycohydrolases, in the molecular mechanisms involved in the regulation of the inflammatory 
response in Cystic Fibrosis lung disease.  
The first challenge was to choose the appropriate cellular models suitable to mimic the characteristic 
condition of the airway of CF patients, especially in term of sphingolipid profile.  
Among the different cellular models available, CuFi-1 and NuLi-1 cell lines represent the most 
promising. CuFi-1 are immortalized bronchial epithelial cells deriving from a CF patients 
homozygous for F508del.  NuLi-1 are cells of the same origin, deriving from a healthy subject. 
Interestingly, both cell lines are characterized by a SLs composition that recalls the features found in 
the lung tissue of CF patient.  
In particular, I found an important difference in the composition of gangliosides between CuFi-1 and 
NuLi-1 cells. In fact, the main ganglioside of CuFi-1 cells is GM3, whereas in NuLi-1 cells is GM1. 
The composition found in CuFi-1 and NuLi-1 cells is related to the characteristics found in lung 
tissue. Indeed, in adult human lung, fourteen gangliosides with different carbohydrate moieties have 
been identified and the most abundant are monosialogangliosides GM3 and GM1 [Mansson, Mo, et 
al. 1986]. In addition, the difference between CF and non-CF cell lines in term of ganglioside 
composition, remind to some evidence reported by Itokazu and colleagues [Itokazu, Pagano, et al. 
2014]. They described a direct correlation between ganglioside GM1 levels at the PM and CFTR 
expression and they demonstrated that the lack of CFTR is responsible for the reduction of the cellular 
level of GM1.  
In addition, as found in CF lung tissue [Brodlie, McKean, et al.], CuFi-1 cells are characterized by a 
high content of ceramide.  
Interestingly, I observed that CuFi-1 cells are characterized by higher activity of the PM-associated 
glycohydrolases when compared to NuLi-1, suggesting that part of the ceramide could be directly 
produced at the cell surface.  
In fact, ceramide is an important factor in pulmonary host defense, in addition to the classical 
cytokines and chemokines, released by the respiratory epithelium. Different findings have 
demonstrated the involvement of Cer in pulmonary infections caused by a variety of bacterial and 
viral pathogens, including Pseudomonas aeruginosa [Seitz, Grassme, et al. 2015].  
The main open question to be addressed is correlated to the relationship between ceramide and 
infection/inflammation. In particular, from the literature it is not clear if the plasma membrane 
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ceramide accumulation is an intrinsic feature of CF bronchial epithelial cells or if the ceramide is 
produced in response to bacterial infection.  
In order to study the effect of the bacterial infection on the SL pattern, I infected both CuFi-1 and 
Nuli-1 cells with PAO-1 and then I analyzed the SL composition. In CuFi-1 cells, I observed a 
significant increase in ceramide and GlcCer content; whereas in NuLi-1 cells the effect of PAO-1 
results only in a slight increase in ceramide content without affecting other cellular sphingolipids. 
As well known, the study of sphingolipids, in particular the study of ceramide remains a critical issue 
for several reason especially for the lack of specific antibodies or probes.  
For these reason, we think that the study of SLs composition and pattern within various cellular 
process must be followed by the measurement of the related metabolic pathway. 
Consequently, after the SLs analysis, I proceed with the measurement of the main glycohydrolases 
involved in the GLSs catabolism, since Grassme and colleagues [Grassme, Jendrossek, et al. 2003] 
excluded the activation of the de-novo ceramide biosynthesis in response to PAO-1 infection. 
Surprisingly, I found that the bacterial infection was not able to cause significant modification on all 
the hydrolases activities tested, associated with PM and in total cell lysate. 
Since I found an enrichment of ceramide content after bacterial infection, I expected to observe some 
modification in the activity of the hydrolases involved in the GLS catabolism, leading to ceramide 
formation. On the other hand, the methodology used to measure the enzymatic activities associated 
with PM allow evaluating the activities associate to the entire cell surface, without the possibility to 
focus on specific membrane areas. 
Starting from these consideration, I begun to taking into account a possible role of lipid rafts in the 
process of bacterial infection and in the mechanism of activation of inflammatory response.  
On this frame, some evidences in literature reported that Cer-enriched membrane domains recruit and 
activate receptors and signalling molecules involved in different inflammatory pathways [Grassme, 
Jendrossek, et al. 2003]. In addition, it has been shown that Cer-enriched platforms are formed in 
cells, after the application of many different stimuli, including bacterial infections [Seitz, Grassme, 
et al. 2015]. However, several questions remain to be addressed especially in CF bronchial epithelial 
cells. 
To this purpose, I prepared the lipids rafts as detergent resistant membrane fraction, from both CuFi-
1 and NuLi-1 cells subjected or not to PAO-1 infection. The first evidence that I obtained was a clear 
effect of the bacterial infection on the DRM organization. In fact, the DRM of infected cells was 
characterized by increased SL-radioactivity with respect to uninfected cells.   
Focusing on CuFi-1 cells, in term of SL composition, I found an enrichment in ceramide, 
sphingomyelin and GM1 in the DRM fraction of infected cells, whereas the complex ganglioside  
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GD1a decreased. The shift from complex to simple sphingolipids suggest the local activation of the 
catabolic machinery. As expected, I found that P.aeruginosa infection leads to an increase of the all 
glycohydrolase activity tested in the DRM fraction.  
On the contrary, in NuLi-1 cells, I observed an enrichment in sphingomyelin, GM1 and GM3 with 
no effect on the ceramide content in the DRM fraction of infected cells. Interestingly, I found that all 
the glycohydrolases activity associated with the DRM fraction of infected cells decreased compared 
to not infected cells. 
Taken together these results lead to speculate that in CF cells, the bacterial infection causes an 
important rearrangement of the PM structure and composition. In particular, the bacterial infection 
leads to a recruitment of the glycohydrolases in specific membrane domains, enriched in their 
substrates. The concomitant presence of the glycohydrolases and their substrate causes changes in the 
SL composition that together with the ceramide formation organizes specific platform involved in the 
activation of the inflammatory response.  
It is quite difficult to speculate between the different behavior of DRM-associated glycohydrolases 
in response to P. aeruginosa infection in CuFi-1 and NuLi-1 cells. The obtained experimental 
evidences suggest that the glycohydrolases involved in the glycosphingolipids catabolism have an 
important role in the establishment of a membrane environment suitable to manage the bacterial 
infection. 
To this purpose, it is important to highlight that the mechanism of bacterial infection management are 
deeply different between CF and non-CF cells and could allow us giving an initial interpretation to 
our intricate results. For instance, although it is generally thought that P. aeruginosa is an 
extracellular pathogen, a number of different groups have found that this bacterium can be 
internalized in different cell types, including airways epithelial cells [Fleiszig, Zaidi, et al. 1996]; 
[Evans, Frank, et al. 1998];[Plotkowski, de Bentzmann, et al. 1999].  
In addition, Pier and co-workers, suggested that CFTR is a cell surface receptor for non-mucoid 
smooth strains of P. aeruginosa. [Pier, Grout, et al. 1996]. They demonstrated that this strain can bind 
via LPS to a specific segment of the CFTR, leading to internalization into bronchial epithelial cells. 
Taken together, all these studies suggest that CFTR is involved in the bacterial internalization.  
Based on these evidences it is reasonable to think that in NuLi-1 cells CFTR, together with the 
hydrolases and sphingolipids, organizes a membrane domain that in response to the bacterial infection 
leads to its internalization. Conversely, in CuFi-1 cells, the ceramide-enriched domain could be 
involved in the activation of the inflammatory response.  
Since the aberrant inflammatory response is one of the main factor responsible for the onset of CF 
lung disease, I further investigated the role of SLs and SL catabolism in the inflammation and host  
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defense in CF epithelial bronchial cells. In particular, I focused my attention on the study of the 
possible molecular mechanism linking the cell membrane micro-domains to the activation of the 
inflammatory response.  
One of the best candidate is represented by the integral membrane receptor CD95. In particular, CD95 
is able to induce both pro-apoptotic and anti-apoptotic signals by its segregation in ceramide-enriched 
domain.  
During the early phase of activation, CD95 recruits phospho-FADD and pro-caspase-8. The 
aggregation of these molecules is able to translocate into lipid rafts domain crating a dimer. At this 
stage, CD95 has the potential to activate non-apoptotic pathway by inducing the activation of the 
mitogen activated protein kinase (MAPK) and the transcription nuclear factor kB (NF-kB) [Grassmé, 
Jekle, et al. 2001]. 
In the late phase of CD95 pathway, after its triggering, CD95 is internalized in a clatrhrin-dependent 
manner into endosomal compartment. During endosomal trafficking, high levels of death-inducing 
signaling complex (DISC) and caspase-8 are recruited, resulting in a strong caspase-8 activation and 
as consequences, the propagation of apoptotic signaling.[Schutze, Tchikov, et al. 2008] However, the 
internalization of CD95 is dependent by the presence of the scaffolding protein EZRIN in its 
phosphorylated state. However, after PAO1 infection in CuFi-1 cells I observed an increase in the 
DRM ceramide content, which is an inhibitor of EZRIN phosphorylation [Adada, Canals, et al. 2014]. 
In this scenario, CD95 is not internalized and remains at the cell surface where activates the pro-
inflammatory pathway promoting the nuclear translocation of the transcription factor NF-kB 
[Grassmé, Jekle, et al. 2001] [Bezzerri, Borgatti, et al. 2008]. The preliminary results obtained, 
support the involvement of this pathway, since I observed an increase of all the principal regulatory 
protein of the pro-inflammatory pathway like phospo-FADD, RIP and NF-kB. 
 
Involvement of GBA2 in the inflammation response in CF lung disease 
 
Among the hydrolases associated with the cell surface, GBA2 represents an important player in the 
regulation of the sphingolipid homeostasis directly at the plasma membrane. In addition, recent 
evidences support its direct role in the regulation of the inflammatory response in CF bronchial 
epithelial cells subjected to bacterial infection. Unfortunately, the experimental approach used for the 
DRM isolation does not allow studying the involvement of GBA2 because of the use of detergent, 
necessary for DRM isolation, inhibits its activity. In addition, the lack of specific antibodies does not 
permit its detection neither in the gradient fraction nor at the cell surface. For this reason, in order to 
study the GBA2 contribute in the inflammation response, I decided to change strategy, overexpressing 
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GBA2 tagged with GFP at the C-terminal in both CuFi-1 and NuLi-1 cells. As expected, I obtained 
monoclonal cell lines stably overexpressing GBA2 at the cell surface, as demonstrated by confocal 
microscopy analyses and enzymatic activity assays on living cells.  
Interestingly, the subcellular localization of the overexpressed enzymes in the two different cell lines 
recall the endogenous GBA2. GBA2 enzymatic activity on PM is major in CuFi-1 with respect to 
NuLi-1 cells, conversely the enzymatic activity associate with cell lysate is major in NuLi-1 in respect 
to CuFi-1. Similarly, overexpressed GBA2 is preponderant on PM of CuFi-1 compared with NuLi-1. 
On the other hand, intracellularly the behavior is opposite, and I found a major activity in NuLi-1 in 
respect to CuFi-1 cells. These considerations suggest that the overexpressing cells preserve the 
original characteristics of CuFi-1 and NuLi-1 cells and represent a good model to study GBA2 
involvement during infection and inflammatory response. GBA2 overexpressing cells are 
characterized by a different SLs profile if compared with Mock control cells. In particular, both CuFi-
1 and NuLi-1 cells overexpressing GBA2 show a decrease of GlcCer, followed by an increase of Cer 
and SM. 
It is possible to explain the relationship between the GlcCer reduction and the Cer increase, 
considering that GBA2 catalyzes the degradation of GlcCer into Ceramide. On the other hand, the 
high content of ceramide is probably associated to an increased synthesis of SM as suggested by Sorli 
and colleagues [Sorli, Colie, et al. 2013]. This could explain the high level of SM observed in the 
overexpressing cells.  
The evidence reported by Loberto and colleagues [Loberto, Tebon, et al. 2014] demonstrating the 
reduction of pro-inflammatory response of CF bronchial epithelial cells after GBA2 knock-down, 
prompted us to evaluated the inflammatory state of CuFi-1 cells overexpressing GBA2 compared to 
CuFi-1 cells. Interestingly, I observed an increase in the basal level of IL-8 mRNA in the GBA2 
overexpressing cells with respect to CuFi-1 cells. These results further support the role of GBA2 in 
the activation of the inflammatory response in CF; in fact, any effect was observed in NuLi-1 cells.  
From the data obtained by PAO-1 infection in CF bronchial epithelial cells, clearly emerge a role of 
lipids rafts in the regulation of the IL-8 expression and secretion.  
As mentioned above, GBA2 overexpression induce changes in the sphingolipid profile causing an 
increase in the ceramide content which is followed by an augmented production of IL-8. On the basis 
on this analogy, I decided to investigate the effect of GBA2 overexpression on the lipids rafts of CuFi-
1 cells. Interestingly I found that DRM deriving from overexpressing cells is characterized by 
increased content of ceramide and by increased activity of the main glycohydrolases, involved in the 
glycosphingolipids catabolism. Interestingly, these data let us to speculate that the overexpression of 
GBA2 mimics the PAO-1 infection. In addition, GBA2 overexpressing cells do not react to the PAO-
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1 infection since show decreased DRM-associated glycohydrolases activity as well as decreased 
ceramide and SM content. In this context, GBA2  overexpression seems to by-pass the effect of PAO-
1 infection at the cell plasma membrane level. Of course, this is a speculation that need additional 
studies to be validated.  
 
Development and characterization of Nanoparticles-based siRNA-GBA2 
delivering system 
 
Among all glycohydrolases, the obtained data, suggest that GBA2 could cover an important role in 
the creation of the pro-inflammatory state characteristic of Cystic Fibrosis lung disease as well as in 
the inflammatory response to bacterial infection.  
In particular, its silencing could represent a new promising therapeutic strategy to reduce the pro-
inflammatory state of CF bronchial epithelial cells and to reduce the inflammatory response after 
bacterial infection. For these reasons, the second objective of my work was to set up a new strategy 
to delivery siRNA in CF epithelial bronchial cell in order to knock down GBA2.  
Certainly, GBA2 plays a crucial role in the extra-lysosomal GlcCer catabolism, producing ceramide 
that can be then rapidly converted into sphingomyelin and seems to play a crucial role in the motor-
neuronal development in fetus [Boot, Verhoek, et al. 2007] [Martin, Schule, et al. 2013, Sorli, Colie, 
et al. 2013]. However, the inhibition of GBA2 as possible therapeutic strategy to reduce CF 
inflammation could be considered only postnatally and this scenario could present very limited side 
effect.  
Moreover, GBA2 activation causes the phosphorylation of eukaryotic initiation factor 2α (eIF2α), 
and this event is associated to an increased expression of ATF4 family of transcription factors. 
Interestingly, phosphorylation of eIF2α has been observed in model of acute infection with 
Clostridium difficile, as part of the mucosal inflammatory response. It can ben speculated that GBA2 
activation by Pseudomonas aeruginosa leads to increased expression of the transcription factors that 
regulates the pro-inflammatory genes in CF bronchial cells. As proof of concept, its pharmacologic 
inhibition with Miglustat and its knocking-down through siRNA leads to a decrease of IL-8 release 
after bacterial infection. The decrease of IL-8 was observed even in absence of bacterial infection 
correlating GBA2 also with the pro-inflammatory state of CF.  
On the bases of these evidence, GBA2 represents a possible molecular target to reduce the 
inflammation caused by pathogens, but also to manage the typical pro-inflammatory state of CF lung 
disease. 
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Even if the pharmacological treatment with Miglustat, drug normally used to manage the Gaucher 
disease, leads to important results, this therapy in Gaucher patients has some limits related to serious 
adverse effect. The most severe is represents by diarrhea, which in particular case could leads to 
death. In addition, no effect in the reduction of the pro-inflammatory state in CF was observed upon 
miglustat treatments.  
For this reason, a new challenge is represented by the development of an innovative approach to 
modulate the function of GBA2.  
At this regard, the other goal of my thesis project was to produce high efficient Nanoparticles, with a 
specific designed multicomponent composition, aimed to obtain a better transfection efficacy of 
siRNA anti-GBA2 and lower toxicity compared with the already available lipid-based systems. 
I first identified the best siRNA sequences in order to silence the activity of GBA2 achieving 70% 
down regulation  in CuFi-1 cells. 
The delivery of genetic material is an important field in continuous development. Lipids and 
DNA/RNA spontaneously aggregate in solution and form structures similar to those of the bare lipids, 
being DNA/RNA embedded in their aqueous moieties. 
For these reasons, lipid-based nanoparticles represent a good solution to promote the transfection of 
genetic material. For in vitro transfection models, the delivery efficiency has been correlated to both 
the lipid composition and the structural features of the lipid/nucleic acid complexes. Thanks to a 
collaboration with the biophysics group belonging to my department I selected a lipid composition 
consisting of a DC-Chol/DOPE mixture that have been already studied for the systemic delivery of 
plasmid DNA and siRNA. 
However, another important point to take into account for the development of nanoparticles for the 
delivery of siRNA, is represented by the fact that RNA is a very unstable molecules, sensible to 
degradation. 
Among lipid-based nanovectors, an interesting class of core-shell nanoparticles have been shown to 
promote transfection efficiency in different experiments. They are obtained by pre-condensing the 
siRNA with a protein, namely protamine, before lipid interaction, in order to protect the siRNA in 
the intracellular environment. 
Taking into account all these considerations, the silencing experiments were performed using a DC-
Chol/DOPE-siRNA lipoplexes (CL) composed only by siRNA and lipids, and DC-Chol/DOPE-
protamine/siRNA nanoparticles (NP), consisted in the interaction between RNA covered by 
protamine and lipids.  
As control, I used a commercial mixture of cationic lipids, the Lipofectamine2000, normally applied 
as vector to administrate siRNA only for research purpose.  
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The first part of the experiments was performed using a florigenic siRNA in order to study its 
localization and stability within CuFi-1 cells. The data obtained from these experiments demonstrated 
that CL an NP carry siRNA in a more efficient way into CuFi-1 cells, compared to Lipofectamine 
2000.  
The second part of the experiment was performed to establish the capability of different delivery 
system to silence GBA2 and their influence on the stability of siRNA into the cells.  
At all the time point considered, NP shows the best down-regulation of GBA2 activity.  
Another important aspect is represented by the toxicity of the different delivery system used. The 
analysis of the cell-damage biochemical markers LC3II, p62 for autophagy and caspase 3 for 
apoptosis reveled that at 48 h, only cells treated with CL are characterized by the activation of macro 
autophagy. The development of NP represents an important field to study new focused delivery 
system, with therapeutic purpose, to diminish and manage collateral and adverse effect.  
Additional investigation are needed to study more in detail the efficiency and the toxicity of this 
delivery system.  
 
Conclusion 
 
In summary, we proposed that Pseudomonas aeruginosa infection in Cystic Fibrosis cells, promotes 
the recruitment at the PM level of the several glycohydrolases involved in the GSLs catabolism, 
creating a platform enriched in ceramide, involved in the activation of inflammatory response. 
In addition, we assumed that GBA2 could cover an important role in this context as well as in the 
establishment of pro-inflammatory state of CF. More important, these results further support the use 
of modulators of SL metabolism as possible therapeutic strategies for CF lung inflammation, concept 
that is becoming increasingly important in the research field of Cystic Fibrosis.  
 
84 Bibliography 
Bibliography  
 
Adada, M., et al., Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications 
for cell dynamics. Biochim Biophys Acta, 2014. 1841(5): p. 727-37. 
Anderson, M.P., et al., Demonstration that CFTR is a chloride channel by alteration of its anion 
selectivity. Science, 1991. 253(5016): p. 202-5. 
Aureli, M., et al., Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts. 
J Inherit Metab Dis, 2012. 35(6): p. 1081-1091. 
Aureli, M., et al., Plasma membrane-associated glycohydrolases along differentiation of murine 
neural stem cells. Neurochem Res, 2012. 37(6): p. 1344-54. 
Aureli, M., et al., Plasma membrane-associated glycohydrolases activation by extracellular 
acidification due to proton exchangers. Neurochem Res, 2012. 37(6): p. 1296-307. 
Aureli, M., et al., Remodeling of sphingolipids by plasma membrane associated enzymes. Neurochem 
Res, 2011. 36(9): p. 1636-44. 
Aureli, M., et al., Cell surface sphingolipid glycohydrolases in neuronal differentiation and aging in 
culture. J Neurochem, 2011. 116(5): p. 891-9. 
Aureli, M., et al., Activity of plasma membrane beta-galactosidase and beta-glucosidase. FEBS Lett, 
2009. 583(15): p. 2469-73. 
Aureli, M., et al., Photoactivable sphingosine as a tool to study membrane microenvironments in 
cultured cells. J Lipid Res, 2010. 51(4): p. 798-808. 
Aureli, M., et al., Erratum to: Current and Novel Aspects on the Non-lysosomal beta-
Glucosylceramidase GBA2. Neurochem Res, 2016. 41(1-2): p. 221. 
Aureli, M., et al., Unravelling the role of sphingolipids in cystic fibrosis lung disease. Chem Phys 
Lipids, 2016. 200: p. 94-103. 
Bartke, N. and Y.A. Hannun, Bioactive sphingolipids: metabolism and function. J Lipid Res, 2009. 
50 Suppl: p. S91-6. 
Becker, K.A., et al., Acid sphingomyelinase inhibitors normalize pulmonary ceramide and 
inflammation in cystic fibrosis. Am J Respir Cell Mol Biol. 42(6): p. 716-24. 
Becker, K.A., et al., The role of sphingolipids and ceramide in pulmonary inflammation in cystic 
fibrosis. Open Respir Med J, 2010. 4: p. 39-47. 
Becker, K.A., et al., Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice 
causes inflammation and cell death. Biochem Biophys Res Commun, 2010. 403(3-4): p. 368-
74. 
Bezzerri, V., et al., Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of 
IL-8 in bronchial cells. Am J Respir Cell Mol Biol, 2008. 39(1): p. 86-96. 
Boot, R.G., et al., Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2. J 
Biol Chem, 2007. 282(2): p. 1305-12. 
Borowitz, D., CFTR, bicarbonate, and the pathophysiology of cystic fibrosis. Pediatr Pulmonol, 2015. 
50 Suppl 40: p. S24-S30. 
Borthwick, L.A., et al., Is CFTR-delF508 really absent from the apical membrane of the airway 
epithelium? PLoS One, 2011. 6(8): p. e23226. 
Boucher, R.C., Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev 
Med, 2007. 58: p. 157-70. 
Boucher, R.C., An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev, 
2002. 54(11): p. 1359-71. 
Brodlie, M., et al., Ceramide is increased in the lower airway epithelium of people with advanced 
cystic fibrosis lung disease. Am J Respir Crit Care Med, 2010. 182(3): p. 369-75. 
Cant, N., N. Pollock, and R.C. Ford, CFTR structure and cystic fibrosis. Int J Biochem Cell Biol, 
2014. 52: p. 15-25. 
 
85 Bibliography 
Cantin, A.M., et al., Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy. J Cyst 
Fibros, 2015. 14(4): p. 419-30. 
Caretti, A., et al., Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic 
potential in cystic fibrosis. Biochim Biophys Acta, 2013. 1840(1): p. 586-94. 
Carter, H.E., et al., Biochemisrty of sphingolipides. III. Structure of sphingosine. J. Biol. Chem., 1947. 
170: p. 285-294. 
Carter, H.E., et al., Biochemistry of the sphingolipids. XIII. Determination of the structure of 
cerebrosides from wheat flour. J Biol Chem, 1961. 236: p. 1912-6. 
Castellani, C., et al., Consensus on the use and interpretation of cystic fibrosis mutation analysis in 
clinical practice. J Cyst Fibros, 2008. 7(3): p. 179-96. 
Chigorno, V., et al., Formation of a cytosolic ganglioside-protein complex following administration 
of photoreactive ganglioside GM1 to human fibroblasts in culture. FEBS Lett, 1990. 263(2): 
p. 329-31. 
Chmiel, J.F., M. Berger, and M.W. Konstan, The role of inflammation in the pathophysiology of CF 
lung disease. Clin Rev Allergy Immunol, 2002. 23(1): p. 5-27. 
Chmiel, J.F. and P.B. Davis, State of the art: why do the lungs of patients with cystic fibrosis become 
infected and why can't they clear the infection? Respir Res, 2003. 4: p. 8. 
Coakley, R.D., et al., Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial 
epithelium. Proc Natl Acad Sci U S A, 2003. 100(26): p. 16083-8. 
Couet, J., et al., Identification of peptide and protein ligands for the caveolin-scaffolding domain. 
Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem, 
1997. 272(10): p. 6525-33. 
De Lisle, R.C., Pass the bicarb: the importance of HCO3- for mucin release. J Clin Invest, 2009. 
119(9): p. 2535-7. 
Dechecchi, M.C., et al., Modulators of sphingolipid metabolism reduce lung inflammation. Am J 
Respir Cell Mol Biol, 2011. 45(4): p. 825-33. 
Dechecchi, M.C., et al., Anti-inflammatory effect of miglustat in bronchial epithelial cells. J Cyst 
Fibros, 2008. 7(6): p. 555-65. 
Degroote, S., J. Wolthoorn, and G. van Meer, The cell biology of glycosphingolipids. Semin Cell Dev 
Biol, 2004. 15(4): p. 375-87. 
Elborn, J.S., Cystic fibrosis. Lancet, 2016. 388(10059): p. 2519-2531. 
Ellsworth, R.E., et al., Comparative genomic sequence analysis of the human and mouse cystic 
fibrosis transmembrane conductance regulator genes. Proc Natl Acad Sci U S A, 2000. 97(3): 
p. 1172-7. 
Engelhardt, J.F., et al., Expression of the cystic fibrosis gene in adult human lung. J Clin Invest, 1994. 
93(2): p. 737-49. 
Evans, D.J., et al., Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both 
of which involve protein tyrosine kinase activity. Infect Immun, 1998. 66(4): p. 1453-9. 
Fanen, P., A. Wohlhuter-Haddad, and A. Hinzpeter, Genetics of cystic fibrosis: CFTR mutation 
classifications toward genotype-based CF therapies. Int J Biochem Cell Biol, 2014. 52: p. 94-
102. 
Farinha, C.M. and P. Matos, Repairing the basic defect in cystic fibrosis - one approach is not enough. 
FEBS J, 2016. 283(2): p. 246-64. 
Fingerhut, R., et al., Degradation of gangliosides by the lysosomal sialidase requires an activator 
protein. Eur J Biochem, 1992. 208(3): p. 623-9. 
Fleiszig, S.M., et al., Relationship between cytotoxicity and corneal epithelial cell invasion by clinical 
isolates of Pseudomonas aeruginosa. Infect Immun, 1996. 64(6): p. 2288-94. 
Futerman, A.H. and Y.A. Hannun, The complex life of simple sphingolipids. EMBO Rep, 2004. 5(8): 
p. 777-82. 
 
86 Bibliography 
Gatti, R., et al., Comparative study of 15 lysosomal enzymes in chorionic villi and cultured amniotic 
fluid cells. Early prenatal diagnosis in seven pregnancies at risk for lysosomal storage 
diseases. Prenat Diagn, 1985. 5(5): p. 329-36. 
Gault, C.R., L.M. Obeid, and Y.A. Hannun, An overview of sphingolipid metabolism: from synthesis 
to breakdown. Adv Exp Med Biol, 2010. 688: p. 1-23. 
Giussani, P., et al., Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug 
resistance. Int J Mol Sci, 2014. 15(3): p. 4356-92. 
Gobbi, M., et al., Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. 
Biomaterials, 2010. 31(25): p. 6519-29. 
Grassme, H., et al., CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas 
aeruginosa. Int J Med Microbiol. 300(8): p. 578-83. 
Grassmé, H., et al., CD95 signaling via ceramide-rich membrane rafts. J Biol Chem, 2001. 276(23): 
p. 20589-96. 
Grassme, H., et al., Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane 
rafts. Nat Med, 2003. 9(3): p. 322-30. 
Guilbault, C., et al., Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J 
Respir Cell Mol Biol, 2008. 38(1): p. 47-56. 
Guilbault, C., et al., Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected 
by fenretinide. Am J Respir Cell Mol Biol, 2009. 41(1): p. 100-6. 
Gustavsson, J., et al., Localization of the insulin receptor in caveolae of adipocyte plasma membrane. 
FASEB J, 1999. 13(14): p. 1961-71. 
Hakomori, S., Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and 
mediators for cellular interactions. J Biol Chem, 1990. 265(31): p. 18713-6. 
Hamai, H., et al., Defective CFTR increases synthesis and mass of sphingolipids that modulate 
membrane composition and lipid signaling. J Lipid Res, 2009. 50(6): p. 1101-8. 
Hannun, Y.A. and L.M. Obeid, Principles of bioactive lipid signalling: lessons from sphingolipids. 
Nat Rev Mol Cell Biol, 2008. 9(2): p. 139-50. 
Hoegger, M.J., et al., Impaired mucus detachment disrupts mucociliary transport in a piglet model of 
cystic fibrosis. Science, 2014. 345(6198): p. 818-22. 
Hoffman, L.R. and B.W. Ramsey, Cystic fibrosis therapeutics: the road ahead. Chest. 143(1): p. 207-
13. 
Huwiler, A., et al., Physiology and pathophysiology of sphingolipid metabolism and signaling. 
Biochim Biophys Acta, 2000. 1485(2-3): p. 63-99. 
Ichikawa, S. and Y. Hirabayashi, Glucosylceramide synthase and glycosphingolipid synthesis. Trends 
Cell Biol, 1998. 8(5): p. 198-202. 
Itokazu, Y., et al., Reduced GM1 ganglioside in CFTR-deficient human airway cells results in 
decreased beta1-integrin signaling and delayed wound repair. Am J Physiol Cell Physiol, 
2014. 306(9): p. C819-30. 
Jeckel, D., et al., Glucosylceramide is synthesized at the cytosolic surface of various Golgi 
subfractions. J Cell Biol, 1992. 117(2): p. 259-67. 
Kabayama, K., et al., TNFalpha-induced insulin resistance in adipocytes as a membrane 
microdomain disorder: involvement of ganglioside GM3. Glycobiology, 2005. 15(1): p. 21-
9. 
Kabayama, K., et al., Dissociation of the insulin receptor and caveolin-1 complex by ganglioside 
GM3 in the state of insulin resistance. Proc Natl Acad Sci U S A, 2007. 104(34): p. 13678-
83. 
Kerem, B., et al., Identification of the cystic fibrosis gene: genetic analysis. Science, 1989. 245(4922): 
p. 1073-80. 
Kolter, T., R.L. Proia, and K. Sandhoff, Combinatorial ganglioside biosynthesis. J Biol Chem, 2002. 
277(29): p. 25859-62. 
 
87 Bibliography 
Konstan, M.W., et al., Clinical use of Ibuprofen is associated with slower FEV1 decline in children 
with cystic fibrosis. Am J Respir Crit Care Med, 2007. 176(11): p. 1084-9. 
Kytzia, H.J. and K. Sandhoff, Evidence for two different active sites on human beta-hexosaminidase 
A. Interaction of GM2 activator protein with beta-hexosaminidase A. J Biol Chem, 1985. 
260(12): p. 7568-72. 
Lahiri, S. and A.H. Futerman, The metabolism and function of sphingolipids and glycosphingolipids. 
Cell Mol Life Sci, 2007. 64(17): p. 2270-84. 
Levy, M. and A.H. Futerman, Mammalian ceramide synthases. IUBMB Life, 2010. 62(5): p. 347-56. 
Loberto, N., et al., The membrane environment of endogenous cellular prion protein in primary rat 
cerebellar neurons. J Neurochem, 2005. 95(3): p. 771-83. 
Loberto, N., et al., GBA2-encoded beta-glucosidase activity is involved in the inflammatory response 
to Pseudomonas aeruginosa. PLoS One, 2014. 9(8): p. e104763. 
Mansson, J.E., et al., Trisialosyllactosylceramide (GT3) is a ganglioside of human lung. FEBS Lett, 
1986. 196(2): p. 259-62. 
Martin, E., et al., Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron 
defects in hereditary spastic paraplegia. Am J Hum Genet, 2013. 92(2): p. 238-44. 
McCarthy, V.A. and A. Harris, The CFTR gene and regulation of its expression. Pediatr Pulmonol, 
2005. 40(1): p. 1-8. 
Merrill, A.H., Jr., De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol 
Chem, 2002. 277(29): p. 25843-6. 
Merrill, A.H., Jr., Sphingolipid and glycosphingolipid metabolic pathways in the era of 
sphingolipidomics. Chem Rev, 2011. 111(10): p. 6387-422. 
Merrill, A.H., Jr. and D.D. Jones, An update of the enzymology and regulation of sphingomyelin 
metabolism. Biochim Biophys Acta, 1990. 1044(1): p. 1-12. 
Milla, C.E. and R.B. Moss, Recent advances in cystic fibrosis. Curr Opin Pediatr, 2015. 27(3): p. 317-
24. 
Moran, O., On the structural organization of the intracellular domains of CFTR. Int J Biochem Cell 
Biol, 2014. 52: p. 7-14. 
Nahrlich, L., et al., Therapy of CF-patients with amitriptyline and placebo--a randomised, double-
blind, placebo-controlled phase IIb multicenter, cohort-study. Cell Physiol Biochem, 2013. 
31(4-5): p. 505-12. 
Nichols, D.P. and J.F. Chmiel, Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol, 2015. 
50 Suppl 40: p. S39-56. 
O'Sullivan, B.P. and S.D. Freedman, Cystic fibrosis. Lancet, 2009. 373(9678): p. 1891-904. 
Ohanian, J. and V. Ohanian, Sphingolipids in mammalian cell signalling. Cell Mol Life Sci, 2001. 
58(14): p. 2053-68. 
Overkleeft, H.S., et al., Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal 
glucosylceramidase. J Biol Chem, 1998. 273(41): p. 26522-7. 
Perez-Vilar, J. and R.C. Boucher, Reevaluating gel-forming mucins' roles in cystic fibrosis lung 
disease. Free Radic Biol Med, 2004. 37(10): p. 1564-77. 
Pezzulo, A.A., et al., Reduced airway surface pH impairs bacterial killing in the porcine cystic 
fibrosis lung. Nature, 2012. 487(7405): p. 109-13. 
Pier, G.B., et al., Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung 
infections. Science, 1996. 271(5245): p. 64-7. 
Plotkowski, M.C., et al., Pseudomonas aeruginosa internalization by human epithelial respiratory 
cells depends on cell differentiation, polarity, and junctional complex integrity. Am J Respir 
Cell Mol Biol, 1999. 20(5): p. 880-90. 
Poulsen, J.H., et al., Bicarbonate conductance and pH regulatory capability of cystic fibrosis 
transmembrane conductance regulator. Proc Natl Acad Sci U S A, 1994. 91(12): p. 5340-4. 
Prinetti, A., et al., Glycosphingolipid behaviour in complex membranes. Biochim Biophys Acta, 
2009. 1788(1): p. 184-93. 
 
88 Bibliography 
Ramu, Y., Y. Xu, and Z. Lu, Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis 
of sphingomyelin. Proc Natl Acad Sci U S A, 2007. 104(15): p. 6448-53. 
Riordan, J.R., et al., Identification of the cystic fibrosis gene: cloning and characterization of 
complementary DNA. Science, 1989. 245(4922): p. 1066-73. 
Rommens, J.M., et al., Identification of the cystic fibrosis gene: chromosome walking and jumping. 
Science, 1989. 245(4922): p. 1059-65. 
Rother, J., et al., Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated 
by cultured cells. Biochem Biophys Res Commun, 1992. 189(1): p. 14-20. 
Scandroglio, F., et al., Lipid content of brain, brain membrane lipid domains, and neurons from acid 
sphingomyelinase deficient mice. J Neurochem, 2008. 107(2): p. 329-38. 
Schutze, S., V. Tchikov, and W. Schneider-Brachert, Regulation of TNFR1 and CD95 signalling by 
receptor compartmentalization. Nat Rev Mol Cell Biol, 2008. 9(8): p. 655-62. 
Seitz, A.P., et al., Ceramide and sphingosine in pulmonary infections. Biol Chem, 2015. 396(6-7): p. 
611-20. 
Shimeno, H., et al., Partial purification and characterization of sphingosine N-acyltransferase 
(ceramide synthase) from bovine liver mitochondrion-rich fraction. Lipids, 1998. 33(6): p. 
601-5. 
Simons, K. and J.L. Sampaio, Membrane organization and lipid rafts. Cold Spring Harb Perspect 
Biol, 2011. 3(10): p. a004697. 
Sonnino, S. and A. Prinetti, Gangliosides as regulators of cell membrane organization and functions. 
Adv Exp Med Biol, 2010. 688: p. 165-84. 
Sonnino, S. and A. Prinetti, Membrane domains and the "lipid raft" concept. Curr Med Chem, 2013. 
20(1): p. 4-21. 
Sorli, S.C., et al., The nonlysosomal beta-glucosidase GBA2 promotes endoplasmic reticulum stress 
and impairs tumorigenicity of human melanoma cells. FASEB J, 2013. 27(2): p. 489-98. 
Spence, M.W., Sphingomyelinases. Adv Lipid Res, 1993. 26: p. 3-23. 
Stoltz, D.A., D.K. Meyerholz, and M.J. Welsh, Origins of cystic fibrosis lung disease. N Engl J Med, 
2015. 372(4): p. 351-62. 
Stonehouse, M.J., et al., A novel class of microbial phosphocholine-specific phospholipases C. Mol 
Microbiol, 2002. 46(3): p. 661-76. 
Tagami, S., et al., Ganglioside GM3 participates in the pathological conditions of insulin resistance. 
J Biol Chem, 2002. 277(5): p. 3085-92. 
Teichgraber, V., et al., Ceramide accumulation mediates inflammation, cell death and infection 
susceptibility in cystic fibrosis. Nat Med, 2008. 14(4): p. 382-91. 
Tizzano, E.F. and M. Buchwald, CFTR expression and organ damage in cystic fibrosis. Ann Intern 
Med, 1995. 123(4): p. 305-8. 
Trezise, A.E., et al., Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet, 
1993. 2(3): p. 213-8. 
Tsui, L.C. and R. Dorfman, The cystic fibrosis gene: a molecular genetic perspective. Cold Spring 
Harb Perspect Med, 2013. 3(2): p. a009472. 
Uhlig, S. and E. Gulbins, Sphingolipids in the lungs. Am J Respir Crit Care Med, 2008. 178(11): p. 
1100-14. 
van Meer, G. and Q. Lisman, Sphingolipid transport: rafts and translocators. J Biol Chem, 2002. 
277(29): p. 25855-8. 
van Meer, G. and W.L. Vaz, Membrane curvature sorts lipids. Stabilized lipid rafts in membrane 
transport. EMBO Rep, 2005. 6(5): p. 418-9. 
van Meer, G., D.R. Voelker, and G.W. Feigenson, Membrane lipids: where they are and how they 
behave. Nat Rev Mol Cell Biol, 2008. 9(2): p. 112-24. 
Vilela, R.M., et al., Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-
treatment with fenretinide. Int Immunopharmacol, 2006. 6(11): p. 1651-64. 
 
89 Bibliography 
Weiser, N., et al., Paracellular permeability of bronchial epithelium is controlled by CFTR. Cell 
Physiol Biochem, 2011. 28(2): p. 289-96. 
Yamaji, T. and K. Hanada, Sphingolipid metabolism and interorganellar transport: localization of 
sphingolipid enzymes and lipid transfer proteins. Traffic, 2015. 16(2): p. 101-22. 
Yang, Y. and S. Uhlig, The role of sphingolipids in respiratory disease. Ther Adv Respir Dis, 2011. 
5(5): p. 325-44. 
Zabner, J., et al., Development of cystic fibrosis and noncystic fibrosis airway cell lines. Am J Physiol 
Lung Cell Mol Physiol, 2003. 284(5): p. L844-54. 
Zhang, Y., et al., DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors 
on plasmid pDNA and siRNA gene delivery. Int J Pharm, 2010. 390(2): p. 198-207. 
Zschoche, A., et al., Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-
galactosidase in a detergent-free system and its stimulation by sphingolipid activator 
proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis. Eur J 
Biochem, 1994. 222(1): p. 83-90. 
 
 
